{
    "id": "dbpedia_5679_3",
    "rank": 36,
    "data": {
        "url": "https://discovery.ucl.ac.uk/view/people/DWHEE12.date.html",
        "read_more_link": "",
        "language": "en",
        "title": "Browse by UCL people",
        "top_image": "https://discovery.ucl.ac.uk/favicon.ico",
        "meta_img": "https://discovery.ucl.ac.uk/favicon.ico",
        "images": [
            "https://discovery.ucl.ac.uk/images/ucl-widelogo.svg",
            "https://discovery.ucl.ac.uk/images/rss-feed.gif",
            "https://discovery.ucl.ac.uk/style/images/feed-icon-14x14.png",
            "https://discovery.ucl.ac.uk/style/images/feed-icon-14x14.png",
            "https://discovery.ucl.ac.uk/style/images/feed-icon-14x14.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10195386/4.hassmallThumbnailVersion/Wheeler_IL-6%20inhibition%20with%20clazakizumab%20in%20patients%20receiving%20maintenance%20dialysis-%20a%20randomized%20phase%202b%20trial_correction_AOP.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10195389/2.hassmallThumbnailVersion/Wheeler_hyperkalemia_burden_and_treatment_pathways_in.10.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10195382/1.hassmallThumbnailVersion/Clinical%20Outcomes%20in%20Patients%20with%20CKD%20and%20Rapid%20or%20Non-rapid%20eGFR%20Decline%20A%20Report%20from%20the%20DISCOVER%20CKD%20Retrospective%20Coho.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10187996/1.hassmallThumbnailVersion/1-s2.0-S0002870324000334-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10190619/3.hassmallThumbnailVersion/Wheeler_Correction.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10188160/1.hassmallThumbnailVersion/Wheeler_Dapagliflozin%20in%20chronic%20kidney%20disease_VoR.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10193196/1.hassmallThumbnailVersion/The%20long-term%20effects%20of%20dapagliflozin%20in%20chronic%20kidney%20disease%20a%20time-to-event%20analysis.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10195385/1.hassmallThumbnailVersion/Associations%20of%20Cerebral%20Small%20Vessel%20Disease%20and%20Chronic%20Kidney%20Disease%20in%20Patients%20With%20Acute%20Intracerebral%20Hemorrhage%20A%20C.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10195393/1.hassmallThumbnailVersion/Sodium-Glucose%20Cotransporter-2%20Inhibitors%20and%20Major%20Adverse%20Cardiovascular%20Outcomes%20A%20SMART-C%20Collaborative%20Meta-Analysis.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10187922/1.hassmallThumbnailVersion/sfae010.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10190497/1.hassmallThumbnailVersion/s13300-024-01550-5.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10188169/1.hassmallThumbnailVersion/Wheeler_Identifying%20individuals%20at%20risk%20of%20needing%20CKD%20associated%20medications%20in%20a%20European%20kidney%20disease%20cohort_VoR.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10187988/1.hassmallThumbnailVersion/Wheeler_Randomised%2C%20blinded%2C%20cross-over%20evaluation%20of%20the%20palatability%20of%20and%20preference%20for%20different%20potassium%20binders%20in%20participants%20with%20chronic%20hyperkalaemia%20in%20the%20USA%2C%20Canada%20and%20Europe_VoR.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10185750/1.hassmallThumbnailVersion/s41598-023-50507-4.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10164771/2.hassmallThumbnailVersion/Wheeler_DAPA-CKD_Baseline%20Diabetes%20Medications_28JUNE2022_author%20review_ds.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10168692/1.hassmallThumbnailVersion/Wheeler_QOL%20paper%20for%20PIVOTAL%20for%20CJASN%20v9%20SB.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10169471/1.hassmallThumbnailVersion/Wheeler_JAHA.122.028739.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10166583/1.hassmallThumbnailVersion/1-s2.0-S1056872723000090-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10180600/1.hassmallThumbnailVersion/Wheeler_Use%20of%20Analog%20and%20Human%20Insulin%20in%20a%20European%20Hemodialysis%20Cohort%20With%20Type%202%20Diabetes_AOP.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10167974/1.hassmallThumbnailVersion/1-s2.0-S2468024923000463-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10172983/1.hassmallThumbnailVersion/PIIS2468024923012962.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10181954/1.hassmallThumbnailVersion/Wheeler_Evaluating%20the%20effect%20of%20a%20digital%20health%20intervention%20to%20enhance%20physical%20activity%20in%20people%20with%20chronic%20kidney%20disease_AOP.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10182171/1.hassmallThumbnailVersion/ZENITH%20Resubmitted%20Lancet%20Primary%20Manuscript_22%20Sep_FINAL_clean.pdf",
            "https://discovery.ucl.ac.uk/10182171/2.hassmallThumbnailVersion/ZENITH%20Resubmitted%20Lancet%20Supplementary%20appendix_22Sep_FINAL_clean.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10169474/7.hassmallThumbnailVersion/Wheeler_PIIS0085253823003095.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10167511/1.hassmallThumbnailVersion/1-s2.0-S0085253823001436-main%20%281%29.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10171113/1.hassmallThumbnailVersion/Wheeler_infections%20write%20up_v19_DOM_revisions_mj.pdf",
            "https://discovery.ucl.ac.uk/10171113/2.hassmallThumbnailVersion/Wheeler_SSTI%20Sup%202.pdf",
            "https://discovery.ucl.ac.uk/10171113/3.hassmallThumbnailVersion/Wheeler_forest%20plot%20ssti%20pooled_v4_revisions.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10172977/2.hassmallThumbnailVersion/Wheeler_KI-03-23-0298%20KDIGO%20Anemia%202%20conf%20report%20May%209%20resubmit%20KI%2009-05-23%20%282%29.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10172811/1.hassmallThumbnailVersion/ferric_carboxymaltose_in_iron_deficient_patients.184.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10164772/2.hassmallThumbnailVersion/Wheeler_CKD%20PC%205.5.CVD%20and%20future%20KFRT_20220509.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10159059/1.hassmallThumbnailVersion/gfac289.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10180598/7.hassmallThumbnailVersion/Wheeler_Translating%20the%20efficacy%20of%20dapagliflozin%20in%20chronic%20kidney%20disease%20to%20lower%20healthcare%20resource%20utilization%20and%20costs_VoR.pdf",
            "https://discovery.ucl.ac.uk/10180598/8.hassmallThumbnailVersion/Wheeler_Translating%20the%20efficacy%20of%20dapagliflozin%20in%20chronic%20kidney%20disease%20to%20lower%20healthcare%20resource%20utilization%20and%20costs_SuppM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10178857/3.hassmallThumbnailVersion/Werring_Hypertension%20and%20small%20vessel%20disease%20revision%20v1.1%20CLEAN.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10168122/1.hassmallThumbnailVersion/1-s2.0-S0085253823002284-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10175918/1.hassmallThumbnailVersion/Diabetic%20Medicine%20-%202023%20-%20Pollock.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10168442/2.hassmallThumbnailVersion/Wheeler_Manuscript%20eGFR%20slope%20CREDENCE%20trial%20CJASN_submitted%20version%20CJASN.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10184420/3.hassmallThumbnailVersion/Wheeler_Omitted%20Study%20Rationale%20and%20Acknowledgment%20of%20Race%20as%20a%20Social%20Construct_correction_VoR.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10175383/1.hassmallThumbnailVersion/Wheeler__Efficacy%20and%20Safety%20of%20Dapagliflozin%20in%20Patients%20with%20Chronic%20Kidney%20Disease%20across%20the%20Spectrum%20of%20Frailty_AAM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10169475/1.hassmallThumbnailVersion/Wheeler_vart_2023_ld_230064_1681831984.66286.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10169470/1.hassmallThumbnailVersion/Wheeler_s12882-023-03173-7.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10168892/1.hassmallThumbnailVersion/s12325-023-02503-3.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10180599/1.hassmallThumbnailVersion/Wheeler_Estimated%20Glomerular%20Filtration%20Rate%2C%20Albuminuria%2C%20and%20Adverse%20Outcomes_AAM.pdf",
            "https://discovery.ucl.ac.uk/style/images/fileicons/archive.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10166587/1.hassmallThumbnailVersion/1-s2.0-S0272638623005371-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10184362/1.hassmallThumbnailVersion/s11606-023-08397-9.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10145676/7.hassmallThumbnailVersion/Wheeler_Diabetes%20Obesity%20Metabolism%20-%202022%20-%20Agarwal%20-%20Empagliflozin%20and%20incidence%20of%20events%20consistent%20with%20acute%20kidney%20injury%20.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10162071/1.hassmallThumbnailVersion/e066212.full.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10145583/1.hassmallThumbnailVersion/Wheeler_JAHA.121.022003.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10151725/1.hassmallThumbnailVersion/Davenport_s13063-022-06357-y.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10141830/1.hassmallThumbnailVersion/Diabetes%20Obesity%20Metabolism%20-%202022%20-%20Chertow%20-%20Qu%20telet%20%20Body%20Mass%20%20Index%20and%20Effects%20of%20Dapagliflozin%20in%20CKD.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10158135/1.hassmallThumbnailVersion/e064513.full.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10158015/1.hassmallThumbnailVersion/s12916-022-02539-2.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10158020/1.hassmallThumbnailVersion/1-s2.0-S0168822722009317-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10158310/2.hassmallThumbnailVersion/Wheeler_Effects%20of%20Dapagliflozin%20in%20People%20without%20Diabetes%20and%20with%20Microalbuminuria_AAM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10129422/3.hassmallThumbnailVersion/Wheeler_CREDENCE%20AKI%20renal%20safety%20MS_AJKD_JJL-69208_R2_Final.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10157035/2.hassmallThumbnailVersion/Wheeler_Correlates%20and%20Consequences%20of%20an%20Acute%20Change%20in%20eGFR%20in%20Response%20to%20the%20SGLT2%20Inhibitor%20Dapagliflozin%20in%20Patients%20with%20CKD_AAM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10161810/1.hassmallThumbnailVersion/1-s2.0-S2468024922018484-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10144060/1.hassmallThumbnailVersion/1-s2.0-S1262363622000143-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10159040/1.hassmallThumbnailVersion/gfac280.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10161652/1.hassmallThumbnailVersion/Wheeler_DAPA%20DECLARE%20Health%20Economic%20Analysis%20H1242.%20AZ%20-%20Broad%20Population%20CEA%20Manuscript%20-%20Outline%202022.10.28%20pr%20dw.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10146930/1.hassmallThumbnailVersion/Wheeler_SRMA%20SGLT2%20%20hyperkalemia%20submission_R1.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10154239/1.hassmallThumbnailVersion/sfac168.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10145610/1.hassmallThumbnailVersion/Wheeler_PIIS246802492101603X.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10140959/1.hassmallThumbnailVersion/Wheeler_Dapagliflozin%20and%20the%20Incidence%20of%20T2D_LDE_revised_clean.pdf",
            "https://discovery.ucl.ac.uk/10140959/7.hassmallThumbnailVersion/Wheeler_Dapagliflozin%20and%20the%20Incidence%20of%20T2D_LDE_Table%201.pdf",
            "https://discovery.ucl.ac.uk/10140959/13.hassmallThumbnailVersion/Wheeler_Figure%201.pdf",
            "https://discovery.ucl.ac.uk/10140959/18.hassmallThumbnailVersion/Wheeler_Figure%202.pdf",
            "https://discovery.ucl.ac.uk/10140959/26.hassmallThumbnailVersion/Wheeler_Figure%203.pdf",
            "https://discovery.ucl.ac.uk/10140959/31.hassmallThumbnailVersion/Wheeler_Figure%204.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10147381/1.hassmallThumbnailVersion/Wheeler_Efficacy%20and%20Safety%20of%20Daprodustat%20for%20Treatment%20of%20Anemia%20of%20Chronic%20Kidney%20Disease%20in%20Incident%20Dialysis%20Patients%20A%20Randomized%20Clinical%20Trial_VoR.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10152044/1.hassmallThumbnailVersion/1-s2.0-S2468024922013833-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10148426/1.hassmallThumbnailVersion/Empagliflozin%20and%20AKI%20Diabetes%20Care%20accepted%20proof%20version%20DC21-2034.R1_Proof_hi.cleaned.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10149488/1.hassmallThumbnailVersion/Wheeler_Efficacy%20and%20Safety%20of%20Dapagliflozin%20in%20Patients%20With%20CKD%20Across%20Major%20Geographic%20Regions_VoR.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10162200/2.hassmallThumbnailVersion/Wheeler_DAPA-CKD%20CJASN%20Manuscript%20Non-DM%20Lifetime%20Benefit_Revision_01_Clean.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10147930/1.hassmallThumbnailVersion/Waijer2022_Article_EffectOfDapagliflozinOnKidneyA.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10160450/1.hassmallThumbnailVersion/supplementaryfigure2April1.tif",
            "https://discovery.ucl.ac.uk/10160450/2.hassmallThumbnailVersion/Risk%20Factors%20for%20Fracture%20in%20Patients%20with%20Coexisting%20Chronic%20Kidney%20Disease%20and%20Type%202%20Diabetes%20An%20Observational%20Analysis%20f.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10142603/3.hassmallThumbnailVersion/Wheeler_Canagliflozin%20Improves%20Cardiovascular%20and%20Renal%20Outcomes%20across%20Broad%20Geographic%20Regions_AAM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10112499/5.hassmallThumbnailVersion/Wheeler_KEPI-2020-0115-Dritsoula%20et%20al-Manuscript-Revised-V2.pdf",
            "https://discovery.ucl.ac.uk/10112499/10.hassmallThumbnailVersion/Wheeler_Supplementary%20Material-Revised-30.7.2020.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10136771/1.hassmallThumbnailVersion/Manuscript_CJASN_0193_02_21.R1_FINAL_submitted.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10109769/1.hassmallThumbnailVersion/Wheeler_nep.13775.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10122053/1.hassmallThumbnailVersion/Proofs%20ISN%20ACTS%20PIIS0085253820314228_DW.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10140985/1.hassmallThumbnailVersion/Wheeler_DAPA-CKD_UACR%20ms_9AUG2021_clean.pdf",
            "https://discovery.ucl.ac.uk/10140985/7.hassmallThumbnailVersion/Wheeler_DAPA-CKD_eGFR%20slope_supplement_09Aug2021.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10121440/1.hassmallThumbnailVersion/Wheeler_Dapagliflozin%20in%20Patients%20with%20Chronic%20Kidney%20Disease.%20Reply_VoR.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/image.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/image.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/image.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/image.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10131267/9.hassmallThumbnailVersion/Wheeler_Heart%20Failure%20Hospitalization%20in%20Adults%20Receiving%20Hemodialysis%20and%20the%20Effect%20of%20Intravenous%20Iron%20Therapy_AAM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10140984/1.hassmallThumbnailVersion/Wheeler_DAPA-CKD_UACR%20ms_9AUG2021_clean.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10114821/1.hassmallThumbnailVersion/Biomarkers_accepted_version.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10142599/3.hassmallThumbnailVersion/Wheeler_The%20Impact%20of%20Canagliflozin%20on%20the%20Risk%20of%20Neuropathy%20Events-%20Results%20from%20the%20CREDENCE%20Trial_AAM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10146932/1.hassmallThumbnailVersion/Wheeler_Predictors%20of%20stroke%20in%20pivotal%205.1.21_IANPM%20JMcM%20MRW%20SB-sda%20pk%20--%20Iain%27s%20comments.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10116358/1.hassmallThumbnailVersion/CIRCULATIONAHA.120.051675.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10111489/1.hassmallThumbnailVersion/1-s2.0-S0272638620309239-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10140960/1.hassmallThumbnailVersion/Wheeler_CREDENCE_hyperkalemia_EHJsubmission_final%20as%20resubmitted.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10142601/9.hassmallThumbnailVersion/Wheeler_317-OR-%20Efficacy%20and%20Safety%20of%20Dapagliflozin%20by%20Glycemic%20Status%20in%20the%20DAPA-CKD%20Trial_AAM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10131359/17.hassmallThumbnailVersion/Wheeler_DAPA-CKD_A1c_Diabetes%20Care_R1_revised_clean.pdf",
            "https://discovery.ucl.ac.uk/10131359/23.hassmallThumbnailVersion/Wheeler_DAPA-CKD_A1c_Diabetes%20Care_Supplementary%20Materials_revised.pdf",
            "https://discovery.ucl.ac.uk/10131359/5.hassmallThumbnailVersion/Figure%201A.pdf",
            "https://discovery.ucl.ac.uk/10131359/11.hassmallThumbnailVersion/Figure%201B.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10142341/10.hassmallThumbnailVersion/Wheeler_cvab317.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10142602/3.hassmallThumbnailVersion/Wheeler_Dapagliflozin%20and%20the%20Incidence%20of%20Type%202%20Diabetes%20in%20Patients%20with%20Chronic%20Kidney%20Disease_AAM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10118778/1.hassmallThumbnailVersion/1-s2.0-S0002870320304075-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10138633/1.hassmallThumbnailVersion/nejmoa2113380.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10138634/1.hassmallThumbnailVersion/nejmoa2113379.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10141835/1.hassmallThumbnailVersion/nejme2118149.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10122004/1.hassmallThumbnailVersion/Wheeler_DAPA-CKD_Diabetes_and_CKD_aetiology_Revd_Ms_Clean_REVISED15OCT.pdf",
            "https://discovery.ucl.ac.uk/10122004/7.hassmallThumbnailVersion/Wheeler_Suppl_DAPA-CKD_Diab-CKD_aetiology_Revised_Clean_Final_REVISED15OCT.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10122821/1.hassmallThumbnailVersion/379911_0_merged_1590387662.pdf",
            "https://discovery.ucl.ac.uk/10122821/7.hassmallThumbnailVersion/379911_0_unknown_upload_4950399_qnvnvl.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10142600/3.hassmallThumbnailVersion/Wheeler_Kidney%20and%20Cardiovascular%20Effects%20of%20Canagliflozin%20According%20to%20Age%20and%20Sex%20in%20the%20CREDENCE%20Trial_AAM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10089249/3.hassmallThumbnailVersion/Wheeler%20CREDENCE%20HbA1c%20subgroup%20research%20letter%20CIRCULATION%20-%20revised%20track%20changes_JGL-67352%20as%20resubmitted.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10086395/3.hassmallThumbnailVersion/Wheeler_2019%20ESC%20Guidelines%20on%20diabetes%2C%20pre-diabetes%2C%20and%20cardiovascular%20diseases%20developed%20in%20collaboration%20with%20the%20EASD_AAM.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10101682/1.hassmallThumbnailVersion/1-s2.0-S0272638620307198-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10090891/3.hassmallThumbnailVersion/Wheeler_DAPA%20CKD%20Study%20Design%20Manuscript_Styled%20for%20NDT_6Nov2019_R1_RK.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10111476/1.hassmallThumbnailVersion/nejmoa2024816.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10076202/1.hassmallThumbnailVersion/Wheeler_CKD_MBD_AROii_Revision_final.pdf",
            "https://discovery.ucl.ac.uk/10076202/7.hassmallThumbnailVersion/Wheeler_CKD_MBD_AROii_Supplement_Revision.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10095377/3.hassmallThumbnailVersion/Figure%201.png",
            "https://discovery.ucl.ac.uk/10095377/10.hassmallThumbnailVersion/Figure%202.png",
            "https://discovery.ucl.ac.uk/10095377/17.hassmallThumbnailVersion/Figure%203.png",
            "https://discovery.ucl.ac.uk/10095377/22.hassmallThumbnailVersion/Figure%204.png",
            "https://discovery.ucl.ac.uk/10095377/28.hassmallThumbnailVersion/Figure%205.png",
            "https://discovery.ucl.ac.uk/10095377/34.hassmallThumbnailVersion/Figure%206.png",
            "https://discovery.ucl.ac.uk/10095377/39.hassmallThumbnailVersion/Figure%207.png",
            "https://discovery.ucl.ac.uk/10095377/44.hassmallThumbnailVersion/PIVOTAL%20--%20Infections%20manuscript%20Appendix.pdf",
            "https://discovery.ucl.ac.uk/style/images/fileicons/slideshow.png",
            "https://discovery.ucl.ac.uk/10095377/52.hassmallThumbnailVersion/Wheeler_PIVOTAL%20--%20Infections%20manuscript%20revised%20Clean.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10093194/3.hassmallThumbnailVersion/Wheeler_SONG-HD%20CVD%20MI%20Workshop%20report%20-at20200205%20PRLPMVJ_AW%20WCW.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10103399/1.hassmallThumbnailVersion/Wheeler_AJKD%20clean%20resubmitted%2016.01.2020.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10114794/3.hassmallThumbnailVersion/Wheeler_Revised%20CREDENCE%20Canagliflozin%20effect%20Anemia%20MS_JJL-69365_R1_FINAL_as%20submitted%20Lancet%20DE.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10110256/1.hassmallThumbnailVersion/NDT%20Oestradiol%20Manuscript%20CKD%20women%20CKDCS%20Paper%202020.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10090892/3.hassmallThumbnailVersion/Wheeler_gfz292.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10112331/3.hassmallThumbnailVersion/Wheeler_redASZ01-MSS-200691-Dapa-Anemia%20manuscript_25Feb2020-clean.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10065388/10.hassmallThumbnailVersion/Wheeler_1-s2.0-S0085253819301383-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10065834/11.hassmallThumbnailVersion/Wheeler_1-s2.0-S0085253819301073-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10072741/1.hassmallThumbnailVersion/M19-0087-manuscript.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10074175/1.hassmallThumbnailVersion/Wheeler_gfz064.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10071976/1.hassmallThumbnailVersion/Wheeler%20Manuscript%20CKD-PC%204%207%20v27_AJKD%20Rv7_final%20peer%20reviewed.pdf",
            "https://discovery.ucl.ac.uk/10071976/7.hassmallThumbnailVersion/Wheeler%20Supplement%20CKD-PC%204%207_20180808.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10077454/10.hassmallThumbnailVersion/Wheeler%20THELANCETDE-S-19-00554.pdf",
            "https://discovery.ucl.ac.uk/10077454/2.hassmallThumbnailVersion/Supplementary%20appendix_LDE.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10060110/1.hassmallThumbnailVersion/Wheeler_Intravenous%20Iron%20in%20Patients%20Undergoing%20Maintenance%20Hemodialysis_AOP.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10069041/1.hassmallThumbnailVersion/Wheeler_Correction.%20Intravenous%20Iron%20in%20Patients%20Undergoing%20Maintenance%20Hemodialysis_VoR.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10054748/1.hassmallThumbnailVersion/Wheeler_THELANCETDE-D-18-00382R1.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10072768/3.hassmallThumbnailVersion/Pollock_DELIGHT%20manuscript_18Feb19_bergur.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10047501/1.hassmallThumbnailVersion/Wheeler_1-s2.0-S0085253818301364-main.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10041508/1.hassmallThumbnailVersion/Hull_National_CKD_Audit.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10046169/1.hassmallThumbnailVersion/Wheeler%202018_03-04_Revised%20FGF23%20Manuscript-clean-ref%20closed.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10038140/1.hassmallThumbnailVersion/songhdsr.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10055692/1.hassmallThumbnailVersion/Wheeler_Final_20180822.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10041892/1.hassmallThumbnailVersion/Wheeler_KDIGO%20Arrhythmia%20and%20CKD%20FINAL.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10043512/1.hassmallThumbnailVersion/Wheeler_CKD%20PC%204.4%20Potassium_20180103_%20%283%29.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1567642/1.hassmallThumbnailVersion/Baigent_Challenges_conducting_clinical_trials.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10028765/3.hassmallThumbnailVersion/Henderson_GKHS_Theme%208_Complications%20of%20CKD_final%20%283%29.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1532867/1.hassmallThumbnailVersion/Caplin_NDT_LK_maintext_tabs_Sept16_acceptedchanges_extracted.pdf",
            "https://discovery.ucl.ac.uk/1532867/6.hassmallThumbnailVersion/Caplin_NDT_LK_appx_text_tabs%20-%20Nov16.pdf",
            "https://discovery.ucl.ac.uk/1532867/7.hassmallThumbnailVersion/fig1.tif",
            "https://discovery.ucl.ac.uk/1532867/8.hassmallThumbnailVersion/fig2a.tif",
            "https://discovery.ucl.ac.uk/1532867/9.hassmallThumbnailVersion/fig2b.tif",
            "https://discovery.ucl.ac.uk/1532867/10.hassmallThumbnailVersion/fig2c.tif",
            "https://discovery.ucl.ac.uk/1532867/11.hassmallThumbnailVersion/fig3a.tif",
            "https://discovery.ucl.ac.uk/1532867/12.hassmallThumbnailVersion/fig3b.tif",
            "https://discovery.ucl.ac.uk/1532867/13.hassmallThumbnailVersion/fig4.tif",
            "https://discovery.ucl.ac.uk/1532867/63.hassmallThumbnailVersion/fig5a.tif",
            "https://discovery.ucl.ac.uk/1532867/14.hassmallThumbnailVersion/fig5b.tif",
            "https://discovery.ucl.ac.uk/1532867/15.hassmallThumbnailVersion/figappx1.tif",
            "https://discovery.ucl.ac.uk/1532867/16.hassmallThumbnailVersion/figappx2.tif",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10024529/1.hassmallThumbnailVersion/Wheeler_AJKD-D-16-01242_Manuscript_Unmarked_Revision.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1547422/1.hassmallThumbnailVersion/Wheeler_170117_TheLancet-D-16-07352_Revised-2_clean_ISN%20CKD%20Summit%20resubmitted.pdf",
            "https://discovery.ucl.ac.uk/1547422/6.hassmallThumbnailVersion/Wheeler_161219_TheLancet-D-16-07352_Web%20Appendix_ISN_CKD%20summit%20resubmitted.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10037599/1.hassmallThumbnailVersion/Wheeler_Chronic%20Kidney%20Disease%20Final%202312017.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1571587/1.hassmallThumbnailVersion/Wheeler%2C_TMAOrw_FINAL.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/10041686/1.hassmallThumbnailVersion/Wheeler_NDT-SONG_Editorial_R1-Clean.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1570568/1.hassmallThumbnailVersion/Wheeler_GKHS_Theme%208_Complications%20of%20CKD_final.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1569290/24.hassmallThumbnailVersion/Kim_how_do_primary_care_doctors_in_England.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1531979/3.hassmallThumbnailVersion/Wheeler_AJKD-D-16-01242_Manuscript_Unmarked_Revision.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1519835/1.hassmallThumbnailVersion/wheeler_nutrients-08-00608.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1472692/1.hassmallThumbnailVersion/Lessons%20EVOLVE%20CJASN%20resub%20learned-%20clean%20copy-%20oct%209.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1490303/1.hassmallThumbnailVersion/Staplin%20Smoking%20and%20Adverse%20Outcomes%20in%20Patients%20With%20CKD.pdf",
            "https://discovery.ucl.ac.uk/1490303/7.hassmallThumbnailVersion/Staplin%20Smoking%20and%20Adverse%20Outcomes%20in%20Patients%20With%20CKD%20Tables.pdf",
            "https://discovery.ucl.ac.uk/1490303/8.hassmallThumbnailVersion/Staplin%20Smoking%20and%20Adverse%20Outcomes%20in%20Patients%20With%20CKD%20Figures.pdf",
            "https://discovery.ucl.ac.uk/1490303/9.hassmallThumbnailVersion/Staplin%20Smoking%20and%20Adverse%20Outcomes%20in%20Patients%20With%20CKD%20Supplementary%20data%20S1.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1508928/1.hassmallThumbnailVersion/Wheeler_AJKD-D-16-00264R1_clean.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1498351/1.hassmallThumbnailVersion/wheeler_Attached%20standard%20file-%20Longterm%20outcomes%20of%20the%204D%20study%20R1%20revision.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/text.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/1424290/1.hassmallThumbnailVersion/357155.pdf",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png",
            "https://discovery.ucl.ac.uk/images/oagreen.png",
            "https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png",
            "https://cdn.ucl.ac.uk/skins/UCLIndigoSkin/default-theme/images/edit.gif"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "ucl discovery",
            "discovery",
            "open access",
            "open access repository",
            "ucl research",
            "research",
            "ucl library",
            "ucl",
            "theses",
            "journal articles",
            "book chapters",
            "conference proceedings",
            "digital web resources"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "UCL Discovery is UCL's open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.",
        "meta_lang": "en",
        "meta_favicon": "/favicon.ico",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "Apperloo, Ellen M; Neuen, Brendon L; Fletcher, Robert A; Jongs, Niels; Anker, Stefan D; Bhatt, Deepak L; Butler, Javed; ... Heerspink, Hiddo JL; + view all Apperloo, Ellen M; Neuen, Brendon L; Fletcher, Robert A; Jongs, Niels; Anker, Stefan D; Bhatt, Deepak L; Butler, Javed; Cherney, David ZI; Herrington, William G; Inzucchi, Silvio E; Jardine, Meg J; Liu, Chih-Chin; Mahaffey, Kenneth W; McGuire, Darren K; McMurray, John JV; Neal, Bruce; Packer, Milton; Perkovic, Vlado; Sabatine, Marc S; Solomon, Scott D; Staplin, Natalie; Szarek, Michael; Vaduganathan, Muthiah; Wanner, Christoph; Wheeler, David C; Wiviott, Stephen D; Zannad, Faiez; Heerspink, Hiddo JL; - view fewer (2024) Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials. The Lancet Diabetes & Endocrinology , 12 (8) pp. 545-557. 10.1016/S2213-8587(24)00155-4.\n\nCardoza, Kathryn; Kang, Amy; Smyth, Brendan; Yi, Tae Won; Pollock, Carol; Agarwal, Rajiv; Bakris, George; ... Mahaffey, Kenneth W; + view all Cardoza, Kathryn; Kang, Amy; Smyth, Brendan; Yi, Tae Won; Pollock, Carol; Agarwal, Rajiv; Bakris, George; Charytan, David M; de Zeeuw, Dick; Wheeler, David C; Zhang, Hong; Cannon, Christopher P; Perkovic, Vlado; Arnott, Clare; Levin, Adeera; Mahaffey, Kenneth W; - view fewer (2024) Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial. Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics , 26 (9) pp. 3530-3540. 10.1111/dom.15685.\n\nFletcher, Robert A; Herrington, William G; Agarwal, Rajiv; Mayne, Kaitlin J; Arnott, Clare; Jardine, Meg J; Mahaffey, Kenneth W; ... Neuen, Brendon L; + view all Fletcher, Robert A; Herrington, William G; Agarwal, Rajiv; Mayne, Kaitlin J; Arnott, Clare; Jardine, Meg J; Mahaffey, Kenneth W; Perkovic, Vlado; Staplin, Natalie; Wheeler, David C; Chertow, Glenn M; Heerspink, Hiddo JL; Neuen, Brendon L; - view fewer (2024) Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD A Meta-Analysis of CKD Progression Trials. Clinical Journal of the American Society of Nephrology 10.2215/CJN.0000000000000470. (In press).\n\nTangri, Navdeep; Mathur, Vandana S; Bushinsky, David A; Klaerner, Gerrit; Li, Elizabeth; Parsell, Dawn; Stasiv, Yuri; ... Inker, Lesley A; + view all Tangri, Navdeep; Mathur, Vandana S; Bushinsky, David A; Klaerner, Gerrit; Li, Elizabeth; Parsell, Dawn; Stasiv, Yuri; Walker, Michael; Wesson, Donald E; Wheeler, David C; Perkovic, Vlado; Inker, Lesley A; - view fewer (2024) VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of Chronic Kidney Disease in Patients with Metabolic Acidosis. Journal of the American Society of Nephrology 10.1681/ASN.0000000000000292. (In press).\n\nWheeler, David C; Søndergaard, Henning; Gwynn, Cathy; Hedman, Katarina; Hedberg, Jonatan; Allum, Alaster; Chung, Hui-Lan; ... Morris, Jon; + view all Wheeler, David C; Søndergaard, Henning; Gwynn, Cathy; Hedman, Katarina; Hedberg, Jonatan; Allum, Alaster; Chung, Hui-Lan; Någård, Mats; Stjernlöf, Gunilla; Wittbrodt, Eric; Kim, Jennifer; Morris, Jon; - view fewer (2024) Randomised, blinded, cross-over evaluation of the palatability of and preference for different potassium binders in participants with chronic hyperkalaemia in the USA, Canada and Europe: the APPETIZE study. BMJ Open , 14 (2) , Article e074954. 10.1136/bmjopen-2023-074954.\n\nYoung, Hannah ML; Castle, Ellen M; Briggs, Juliet; Walklin, Christy; Billany, Roseanne E; Asgari, Elham; Bhandari, Sunil; ... Greenwood, Sharlene A; + view all Young, Hannah ML; Castle, Ellen M; Briggs, Juliet; Walklin, Christy; Billany, Roseanne E; Asgari, Elham; Bhandari, Sunil; Bishop, Nicolette; Bramham, Kate; Burton, James O; Campbell, Jackie; Chilcot, Joseph; Cooper, Nicola; Deelchand, Vashist; Graham-Brown, Matthew PM; Haggis, Lynda; Hamilton, Alexander; Jesky, Mark; Kalra, Philip A; Koufaki, Pelagia; Macdonald, Jamie; McCafferty, Kieran; Nixon, Andrew C; Noble, Helen; Saynor, Zoe L; Taal, Maarten W; Tollitt, James; Wheeler, David C; Wilkinson, Thomas J; Greenwood, Sharlene A; - view fewer (2024) The development and internal pilot trial of a digital physical activity and emotional well-being intervention (Kidney BEAM) for people with chronic kidney disease. Science Reports , 14 (1) , Article 700. 10.1038/s41598-023-50507-4.\n\nBhandari, Sunil; Parfrey, Patrick; White, Claire; Anker, Stefan D; Farrington, Kenneth; Ford, Ian; Kalra, Philip A; ... PIVOTAL Investigators, Committees; + view all Bhandari, Sunil; Parfrey, Patrick; White, Claire; Anker, Stefan D; Farrington, Kenneth; Ford, Ian; Kalra, Philip A; McMurray, John JV; Robertson, Michele; Tomson, Charles RV; Wheeler, David C; Macdougall, Iain C; PIVOTAL Investigators, Committees; - view fewer (2023) Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomes. Journal of Nephrology , 36 pp. 1651-1662. 10.1007/s40620-023-01571-6.\n\nChertow, Glenn M; Correa-Rotter, Ricardo; Vart, Priya; Jongs, Niels; McMurray, John JV; Rossing, Peter; Langkilde, Anna Maria; ... DAPA‐CKD Trial Committees and Investigators; + view all Chertow, Glenn M; Correa-Rotter, Ricardo; Vart, Priya; Jongs, Niels; McMurray, John JV; Rossing, Peter; Langkilde, Anna Maria; Sjöström, C David; Toto, Robert D; Wheeler, David C; Heerspink, Hiddo JL; DAPA‐CKD Trial Committees and Investigators; - view fewer (2023) Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease , 12 (9) , Article e028739. 10.1161/JAHA.122.028739.\n\nFletcher, Robert A; Jongs, Niels; Chertow, Glenn M; McMurray, John JV; Arnott, Clare; Jardine, Meg J; Mahaffey, Kenneth W; ... Neuen, Brendon L; + view all Fletcher, Robert A; Jongs, Niels; Chertow, Glenn M; McMurray, John JV; Arnott, Clare; Jardine, Meg J; Mahaffey, Kenneth W; Perkovic, Vlado; Rockenschaub, Patrick; Rossing, Peter; Correa-Rotter, Ricardo; Toto, Robert D; Vaduganathan, Muthiah; Wheeler, David C; Heerspink, Hiddo JL; Neuen, Brendon L; - view fewer (2023) Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials. Journal of the American Society of Nephrology 10.1681/ASN.0000000000000248. (In press).\n\nGreenwood, SA; Oliveira, BA; Asgari, E; Ayis, S; Baker, LA; Beckley-Hoelscher, N; Goubar, A; ... Bramham, K; + view all Greenwood, SA; Oliveira, BA; Asgari, E; Ayis, S; Baker, LA; Beckley-Hoelscher, N; Goubar, A; Banerjee, D; Bhandari, S; Chilcot, J; Burton, JO; Kalra, PA; Lightfoot, CJ; Macdougall, IC; McCafferty, K; Mercer, TH; Okonko, DO; Reid, C; Reid, F; Smith, AC; Swift, PA; Mangelis, A; Watson, E; Wheeler, DC; Wilkinson, TJ; Bramham, K; - view fewer (2023) A Randomized Trial of Intravenous Iron Supplementation and Exercise on Exercise Capacity in Iron-Deficient Nonanemic Patients With CKD. Kidney International Reports 10.1016/j.ekir.2023.05.002.\n\nGreenwood, Sharlene A; Young, Hannah ML; Briggs, Juliet; Castle, Ellen M; Walklin, Christy; Haggis, Lynda; Balkin, Caitlin; ... Macdonald, Jamie H; + view all Greenwood, Sharlene A; Young, Hannah ML; Briggs, Juliet; Castle, Ellen M; Walklin, Christy; Haggis, Lynda; Balkin, Caitlin; Asgari, Elham; Bhandari, Sunil; Burton, James O; Billany, Roseanne E; Bishop, Nicolette C; Bramham, Kate; Campbell, Jackie; Chilcot, Joseph; Cooper, Nicola J; Deelchand, Vashist; Graham-Brown, Matthew MP; Hamilton, Alexander; Jesky, Mark; Kalra, Philip A; Koufaki, Pelagia; McCafferty, Kieran; Nixon, Andrew C; Noble, Helen; Saynor, Zoe; Taal, Maarten W; Tollit, James; Wheeler, David C; Wilkinson, Thomas J; Worboys, Hannah; Macdonald, Jamie H; - view fewer (2023) Evaluating the effect of a digital health intervention to enhance physical activity in people with chronic kidney disease (Kidney BEAM): a multicentre, randomised controlled trial in the UK. The Lancet Digital Health 10.1016/S2589-7500(23)00204-2. (In press).\n\nHeerspink, Hiddo L; Jongs, Niels; Schloemer, Patrick; Little, Dustin J; Brinker, Meike; Tasto, Christoph; Karpefors, Martin; ... Gasparyan, Samvel B; + view all Heerspink, Hiddo L; Jongs, Niels; Schloemer, Patrick; Little, Dustin J; Brinker, Meike; Tasto, Christoph; Karpefors, Martin; Wheeler, David C; Bakris, George; Perkovic, Vlado; Nkulikiyinka, Richard; Rossert, Jerome; Gasparyan, Samvel B; - view fewer (2023) Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression. Journal of the American Society of Nephrology 10.1681/ASN.0000000000000243. (In press).\n\nJohansen, Kirsten L; Cobitz, Alexander R; Singh, Ajay K; Macdougall, Iain C; Lopes, Renato D; Obrador, Gregorio T; Kovesdy, Csaba P; ... Wheeler, David C; + view all Johansen, Kirsten L; Cobitz, Alexander R; Singh, Ajay K; Macdougall, Iain C; Lopes, Renato D; Obrador, Gregorio T; Kovesdy, Csaba P; Israni, Rubeen; Jha, Vivekanand; Okoro, Tony; Sprys, Mike; Jolly, Shivinder; Lindsay, Alistair C; Bhatt, Purav; Camejo, Rodrigo Refoios; Keeley, Tom; Cizman, Borut; Wheeler, David C; - view fewer (2023) The ASCEND-NHQ trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis-dependent chronic kidney disease. Kidney International 10.1016/j.kint.2023.02.019. (In press).\n\nKang, Amy; Smyth, Brendan; Neuen, Brendon L; Heerspink, Hiddo JL; Di Tanna, Gian Luca; Zhang, Hong; Arnott, Clare; ... Jardine, Meg J; + view all Kang, Amy; Smyth, Brendan; Neuen, Brendon L; Heerspink, Hiddo JL; Di Tanna, Gian Luca; Zhang, Hong; Arnott, Clare; Hockham, Carinna; Agarwal, Rajiv; Bakris, George; Charytan, David M; de Zeeuw, Dick; Greene, Tom; Levin, Adeera; Pollock, Carol; Wheeler, David C; Mahaffey, Kenneth W; Perkovic, Vlado; Jardine, Meg J; - view fewer (2023) The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials. Diabetes, Obesity and Metabolism , 25 (8) pp. 2151-2162. 10.1111/dom.15091.\n\nMacdougall, Iain C; Ponikowski, Piotr; Stack, Austin G; Wheeler, David C; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; ... Jankowska, Ewa A; + view all Macdougall, Iain C; Ponikowski, Piotr; Stack, Austin G; Wheeler, David C; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Göhring, Udo-Michael; Kirwan, Bridget-Anne; Kumpeson, Vasuki; Metra, Marco; Rosano, Giuseppe; Ruschitzka, Frank; van der Meer, Peter; Wächter, Sandra; Jankowska, Ewa A; - view fewer (2023) Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function. Clinical Journal of the American Society of Nephrology 10.2215/CJN.0000000000000223. (In press).\n\nMathur, Vandana S; Bushinsky, David A; Inker, Lesley; Klaerner, Gerrit; Li, Elizabeth; Parsell, Dawn; Perkovic, Vlado; ... Tangri, Navdeep; + view all Mathur, Vandana S; Bushinsky, David A; Inker, Lesley; Klaerner, Gerrit; Li, Elizabeth; Parsell, Dawn; Perkovic, Vlado; Stasiv, Yuri; Walker, Michael; Wesson, Donald E; Wheeler, David C; Tangri, Navdeep; - view fewer (2023) Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis. Nephrology Dialysis Transplantation , 38 (6) pp. 1448-1458. 10.1093/ndt/gfac289.\n\nSridhar, Vikas S; Neuen, Brendon L; Fletcher, Robert A; Slee, April; Ang, Fernando G; Rapattoni, Wally; Arnott, Clare; ... Levin, Adeera; + view all Sridhar, Vikas S; Neuen, Brendon L; Fletcher, Robert A; Slee, April; Ang, Fernando G; Rapattoni, Wally; Arnott, Clare; Cherney, David Z; Perkovic, Vlado; Wheeler, David C; Levin, Adeera; - view fewer (2023) Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials. Diabetes, Obesity and Metabolism 10.1111/dom.15112. (In press).\n\nTaal, Maarten W; Lucas, Bethany; Roderick, Paul; Cockwell, Paul; Wheeler, David C; Saleem, Moin A; Fraser, Simon DS; ... Kalra, Philip A; + view all Taal, Maarten W; Lucas, Bethany; Roderick, Paul; Cockwell, Paul; Wheeler, David C; Saleem, Moin A; Fraser, Simon DS; Banks, Rosamonde E; Johnson, Tim; Hale, Lorna J; Andag, Uwe; Skroblin, Philipp; Bayerlova, Michaela; Unwin, Robert; Vuilleumier, Nicolas; Dusaulcy, Rodolphe; Robertson, Fiona; Colby, Elizabeth; Pitcher, David; Braddon, Fiona; Benavente, Melissa; Davies, Elaine; Nation, Michael; Kalra, Philip A; - view fewer (2023) Associations with age and glomerular filtration rate in a referred population with chronic kidney disease: Methods and baseline data from a UK multicentre cohort study (NURTuRE-CKD). Nephrology Dialysis Transplantation , Article gfad110. 10.1093/ndt/gfad110. (In press).\n\nVart, Priya; Butt, Jawad H; Jongs, Niels; Schechter, Meir; Chertow, Glenn M; Wheeler, David C; Pecoits-Filho, Roberto; ... Heerspink, Hiddo JL; + view all Vart, Priya; Butt, Jawad H; Jongs, Niels; Schechter, Meir; Chertow, Glenn M; Wheeler, David C; Pecoits-Filho, Roberto; Langkilde, Anna Maria; Correa-Rotter, Ricardo; Rossing, Peter; McMurray, John JV; Heerspink, Hiddo JL; - view fewer (2023) Efficacy and Safety of Dapagliflozin in Patients with Chronic Kidney Disease across the Spectrum of Frailty. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences , Article glad181. 10.1093/gerona/glad181. (In press).\n\nWalklin, CG; Young, Hannah ML; Asghari, E; Bhandari, S; Billany, RE; Bishop, N; Bramham, K; ... Greenwood, SA; + view all Walklin, CG; Young, Hannah ML; Asghari, E; Bhandari, S; Billany, RE; Bishop, N; Bramham, K; Briggs, J; Burton, JO; Campbell, J; Castle, EM; Chilcot, J; Cooper, N; Deelchand, V; Graham-Brown, MPM; Hamilton, A; Jesky, M; Kalra, PA; Koufaki, P; McCafferty, K; Nixon, AC; Noble, H; Saynor, ZL; Sothinathan, C; Taal, MW; Tollitt, J; Wheeler, DC; Wilkinson, TJ; Macdonald, JH; Greenwood, SA; - view fewer (2023) The effect of a novel, digital physical activity and emotional well-being intervention on health-related quality of life in people with chronic kidney disease: trial design and baseline data from a multicentre prospective, wait-list randomised controlled trial (kidney BEAM). BMC Nephrology , 24 , Article 122. 10.1186/s12882-023-03173-7.\n\nWriting Group for the CKD Prognosis, Consortium; Grams, Morgan E; Coresh, Josef; Matsushita, Kunihiro; Ballew, Shoshana H; Sang, Yingying; Surapaneni, Aditya; ... Gansevoort, Ron T; + view all Writing Group for the CKD Prognosis, Consortium; Grams, Morgan E; Coresh, Josef; Matsushita, Kunihiro; Ballew, Shoshana H; Sang, Yingying; Surapaneni, Aditya; Alencar de Pinho, Natalia; Anderson, Amanda; Appel, Lawrence J; Ärnlöv, Johan; Azizi, Fereidoun; Bansal, Nisha; Bell, Samira; Bilo, Henk JG; Brunskill, Nigel J; Carrero, Juan J; Chadban, Steve; Chalmers, John; Chen, Jing; Ciemins, Elizabeth; Cirillo, Massimo; Ebert, Natalie; Evans, Marie; Ferreiro, Alejandro; Fu, Edouard L; Fukagawa, Masafumi; Green, Jamie A; Gutierrez, Orlando M; Herrington, William G; Hwang, Shih-Jen; Inker, Lesley A; Iseki, Kunitoshi; Jafar, Tazeen; Jassal, Simerjot K; Jha, Vivekanand; Kadota, Aya; Katz, Ronit; Köttgen, Anna; Konta, Tsuneo; Kronenberg, Florian; Lee, Brian J; Lees, Jennifer; Levin, Adeera; Looker, Helen C; Major, Rupert; Melzer Cohen, Cheli; Mieno, Makiko; Miyazaki, Mariko; Moranne, Olivier; Muraki, Isao; Naimark, David; Nitsch, Dorothea; Oh, Wonsuk; Pena, Michelle; Purnell, Tanjala S; Sabanayagam, Charumathi; Satoh, Michihiro; Sawhney, Simon; Schaeffner, Elke; Schöttker, Ben; Shen, Jenny I; Shlipak, Michael G; Sinha, Smeeta; Stengel, Benedicte; Sumida, Keiichi; Tonelli, Marcello; Valdivielso, Jose M; van Zuilen, Arjan D; Visseren, Frank LJ; Wang, Angela Yee-Moon; Wen, Chi-Pang; Wheeler, David C; Yatsuya, Hiroshi; Yamagata, Kunihiro; Yang, Jae Won; Young, Ann; Zhang, Haitao; Zhang, Luxia; Levey, Andrew S; Gansevoort, Ron T; - view fewer (2023) Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes. An Individual-Participant Data Meta-Analysis. JAMA: Journal of the American Medical Association , 330 (13) pp. 1266-1277. 10.1001/jama.2023.17002.\n\nYi, TW; Wong, MMY; Neuen, BL; Arnott, C; Poirier, P; Seufert, J; Slee, A; ... Levin, A; + view all Yi, TW; Wong, MMY; Neuen, BL; Arnott, C; Poirier, P; Seufert, J; Slee, A; Rapattoni, W; Ang, FG; Wheeler, DC; Mahaffey, KW; Perkovic, V; Levin, A; - view fewer (2023) Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial. Diabetes, Obesity and Metabolism 10.1111/dom.15065.\n\nCaskey, FJ; Procter, S; MacNeill, SJ; Wade, J; Taylor, J; Rooshenas, L; Liu, Y; ... Lane, JA; + view all Caskey, FJ; Procter, S; MacNeill, SJ; Wade, J; Taylor, J; Rooshenas, L; Liu, Y; Annaw, A; Alloway, K; Davenport, A; Power, A; Farrington, K; Mitra, S; Wheeler, DC; Law, K; Lewis-White, H; Ben-Shlomo, Y; Hollingworth, W; Donovan, J; Lane, JA; - view fewer (2022) The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes. Trials , 23 , Article 532. 10.1186/s13063-022-06357-y.\n\nGreenwood, Sharlene A; Beckley-Hoelscher, Nicholas; Asgari, Elham; Ayis, Salma; Baker, Luke A; Banerjee, Debasish; Bhandari, Sunil; ... Macdougall, Iain C; + view all Greenwood, Sharlene A; Beckley-Hoelscher, Nicholas; Asgari, Elham; Ayis, Salma; Baker, Luke A; Banerjee, Debasish; Bhandari, Sunil; Bramham, Kate; Chilcot, Joseph; Burton, James; Kalra, Philip A; Lightfoot, Courtney J; McCafferty, Kieran; Mercer, Thomas H; Okonko, Darlington O; Oliveira, Benjamin; Reid, Chante; Smith, Alice C; Swift, Pauline A; Mangelis, Anastasios; Watson, Emma; Wheeler, David C; Wilkinson, Thomas J; Reid, Fiona; Macdougall, Iain C; - view fewer (2022) The effect of intravenous iron supplementation on exercise capacity in iron-deficient but not anaemic patients with chronic kidney disease: study design and baseline data for a multicentre prospective double-blind randomised controlled trial. BMC Nephrology , 23 (1) , Article 268. 10.1186/s12882-022-02896-3.\n\nJongs, Niels; Chertow, Glenn M; Greene, Tom; McMurray, John JV; Langkilde, Anna Maria; Correa-Rotter, Ricardo; Kashihara, Naoki; ... DAPA-CKD Trial Committees and Investigators, .; + view all Jongs, Niels; Chertow, Glenn M; Greene, Tom; McMurray, John JV; Langkilde, Anna Maria; Correa-Rotter, Ricardo; Kashihara, Naoki; Rossing, Peter; Sjöström, C David; Stefánsson, Bergur V; Toto, Robert D; Wheeler, David C; Heerspink, Hiddo JL; DAPA-CKD Trial Committees and Investigators, .; - view fewer (2022) Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD. Journal of the American Society of Nephrology , 33 (10) , Article 2022030306. 10.1681/ASN.2022030306.\n\nLalayiannis, AD; Crabtree, NJ; Ferro, CJ; Wheeler, DC; Duncan, ND; Smith, C; Popoola, J; ... Shroff, R; + view all Lalayiannis, AD; Crabtree, NJ; Ferro, CJ; Wheeler, DC; Duncan, ND; Smith, C; Popoola, J; Varvara, A; Mitsioni, A; Kaur, A; Sinha, MD; Biassoni, L; McGuirk, SP; Mortensen, KH; Milford, DV; Long, J; Leonard, MD; Fewtrell, M; Shroff, R; - view fewer (2022) Bone Mineral Density and Vascular Calcification in Children and Young Adults With CKD 4 to 5 or on Dialysis. Kidney International Reports 10.1016/j.ekir.2022.10.023. (In press).\n\nLi, Jing-Wei; Arnott, Clare; Heerspink, Hiddo JL; MBiostat, Qiang Li; Cannon, Christopher P; Wheeler, David C; Charytan, David M; ... Jardine, Meg J; + view all Li, Jing-Wei; Arnott, Clare; Heerspink, Hiddo JL; MBiostat, Qiang Li; Cannon, Christopher P; Wheeler, David C; Charytan, David M; Barraclough, Jennifer; Figtree, Gemma A; Agarwal, Rajiv; Bakris, George; de Zeeuw, Dick; Greene, Tom; Levin, Adeera; Pollock, Carol; Zhang, Hong; Zinman, Bernard; Mahaffey, Kenneth W; Perkovic, Vlado; Neal, Bruce; Jardine, Meg J; - view fewer (2022) Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial. Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease , 11 (16) , Article e025045. 10.1161/JAHA.121.025045.\n\nProvenzano, Michele; Jongs, Niels; Vart, Priya; Stefánsson, Bergur V; Chertow, Glenn M; Langkilde, Anna Maria; McMurray, John JV; ... DAPA-CKD Trial Committees and Investigators; + view all Provenzano, Michele; Jongs, Niels; Vart, Priya; Stefánsson, Bergur V; Chertow, Glenn M; Langkilde, Anna Maria; McMurray, John JV; Correa-Rotter, Ricardo; Rossing, Peter; Sjöström, C David; Toto, Robert D; Wheeler, David C; Heerspink, Hiddo JL; DAPA-CKD Trial Committees and Investigators; - view fewer (2022) The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists. Kidney International Reports , 7 (3) pp. 436-443. 10.1016/j.ekir.2021.12.013.\n\nRossing, P; Inzucchi, SE; Vart, P; Jongs, N; Docherty, KF; Jhund, PS; Kober, L; ... Heerspink, HJL; + view all Rossing, P; Inzucchi, SE; Vart, P; Jongs, N; Docherty, KF; Jhund, PS; Kober, L; Kosiborod, MN; Martinez, FA; Ponikowski, P; Sabatine, MS; Solomon, SD; DeMets, DL; Bengtsson, O; Lindberg, M; Langkilde, AM; Sjostrand, M; Stefansson, B; Karlsson, C; Chertow, GM; Hou, FF; Correa-Rotter, R; Toto, RD; Wheeler, DC; McMurray, JJ; Heerspink, HJL; - view fewer (2022) Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials. Lancet Diabetes and Endocrinology , 10 (1) pp. 24-34. 10.1016/S2213-8587(21)00295-3.\n\nThomson, PC; Mark, PB; Robertson, M; White, C; Anker, SD; Bhandari, S; Farrington, K; ... Andani, S; + view all Thomson, PC; Mark, PB; Robertson, M; White, C; Anker, SD; Bhandari, S; Farrington, K; Jardine, AG; Kalra, PA; McMurray, J; Reddan, D; Wheeler, DC; Winearls, CG; Ford, I; Macdougall, IC; Winnett, G; Akbani, H; Winearls, C; Wessels, J; Ayub, W; Connor, A; Brown, A; Moriarty, J; Chowdury, P; Griffiths, M; Dasgupta, I; Doulton, T; Macdougall, I; Barratt, J; Vilar, E; Mitra, S; Ramakrishna, B; Nicholas, J; Ross, C; Khwaja, A; Hall, M; Kirk, A; Smith, S; Jesky, M; Day, C; Alchi, B; Stratton, J; Clarke, H; Walsh, S; Brown, R; McCafferty, K; Solomon, L; Ramadoss, S; Basanyake, K; Lawman, S; Kalra, P; Balasubramaniam, G; Power, A; Banerjee, D; Swift, P; Wellberry-Smith, M; Goldsmith, C; Ledson, T; Mikhail, A; Benzimra, R; Bell, S; Severn, A; Neary, J; Doyle, A; Thomson, P; Shivashankar, G; Bolton, S; Quinn, M; Maxwell, P; Harty, J; Anker, S; Tomson, C; Wheeler, D; Petrie, M; Connolly, E; Jhund, P; MacDonald, M; Mark, P; Walters, M; Peacock, J; Isles, C; Aziz, J; Boyle, S; Burton, C; Clarke, R; Dinnett, E; Hillen, N; Kean, S; Kerr, C; Murray, H; Reid, A; Wetherall, K; Wilson, R; Andani, S; - view fewer (2022) An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial. Kidney International Reports 10.1016/j.ekir.2022.05.008. (In press).\n\nWilding, JPH; Evans, M; Fernando, K; Gorriz, JL; Cebrian, A; Diggle, J; Hicks, D; ... Del Prato, S; + view all Wilding, JPH; Evans, M; Fernando, K; Gorriz, JL; Cebrian, A; Diggle, J; Hicks, D; James, J; Newland-Jones, P; Ali, A; Bain, S; Da Porto, A; Patel, D; Viljoen, A; Wheeler, DC; Del Prato, S; - view fewer (2022) The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review. Diabetes Therapy 10.1007/s13300-022-01228-w. (In press).\n\nEdwards, NC; Price, AM; Mehta, S; Hiemstra, TF; Kaur, A; Greasley, PJ; Webb, DJ; ... Townend, JN; + view all Edwards, NC; Price, AM; Mehta, S; Hiemstra, TF; Kaur, A; Greasley, PJ; Webb, DJ; Dhaun, N; MacIntyre, IM; Farrah, T; Melville, V; Herrey, AS; Slinn, G; Wale, R; Ives, N; Wheeler, DC; Wilkinson, I; Steeds, RP; Ferro, CJ; Townend, JN; - view fewer (2021) Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label Trial. Clinical Journal of the American Society of Nephrology , 16 (10) pp. 1491-1501. 10.2215/CJN.01930221.\n\nEvangelidis, N; Sautenet, B; Madero, M; Tong, A; Ashuntantang, G; Sanabria, LC; de Boer, IH; ... Craig, JC; + view all Evangelidis, N; Sautenet, B; Madero, M; Tong, A; Ashuntantang, G; Sanabria, LC; de Boer, IH; Fung, S; Gallego, D; Levey, AS; Levin, A; Lorca, E; Okpechi, IG; Rossignol, P; Sola, L; Usherwood, T; Wheeler, DC; Cho, Y; Howell, M; Guha, C; Scholes-Robertson, N; Widders, K; Gonzalez, AM; Teixeira-Pinto, A; Viecelli, AK; Bernier-Jean, A; Anumudu, S; Dunn, L; Wilkie, M; Craig, JC; - view fewer (2021) Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy. Trials , 22 (1) , Article 612. 10.1186/s13063-021-05574-1.\n\nGreenwood, SA; Koufaki, P; Macdonald, J; Bhandari, S; Burton, J; Dasgupta, I; Farrington, K; ... Mercer, TH; + view all Greenwood, SA; Koufaki, P; Macdonald, J; Bhandari, S; Burton, J; Dasgupta, I; Farrington, K; Ford, I; Kalra, PA; Kean, S; Kumwenda, M; Macdougall, IC; Messow, C-M; Mitra, S; Reid, C; Smith, AC; Taal, MW; Thomson, PC; Wheeler, DC; White, C; Yaqoob, M; Mercer, TH; - view fewer (2021) The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trial. Clinical Kidney Journal , 14 (5) pp. 1345-1355. 10.1093/ckj/sfaa107.\n\nGreenwood, SA; Koufaki, P; Macdonald, JH; Bulley, C; Bhandari, S; Burton, JO; Dasgupta, I; ... Mercer, TH; + view all Greenwood, SA; Koufaki, P; Macdonald, JH; Bulley, C; Bhandari, S; Burton, JO; Dasgupta, I; Farrington, K; Ford, I; Kalra, PA; Kumwenda, M; Macdougall, IC; Messow, C-M; Mitra, S; Reid, C; Smith, AC; Taal, MW; Thomson, PC; Wheeler, DC; White, C; Yaqoob, M; Mercer, TH; - view fewer (2021) Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCT. Health Technology Assessment , 25 (40) 10.3310/hta25400.\n\nHeerspink, HJ; Cherney, D; Postmus, D; Stefánsson, BV; Chertow, GM; Dwyer, JP; Greene, T; ... DAPA-CKD trial committees and investigators; + view all Heerspink, HJ; Cherney, D; Postmus, D; Stefánsson, BV; Chertow, GM; Dwyer, JP; Greene, T; Kosiborod, M; Langkilde, AM; McMurray, JJ; Correa-Rotter, R; Rossing, P; Sjöström, CD; Toto, RD; Wheeler, DC; DAPA-CKD trial committees and investigators; - view fewer (2021) A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function. Kidney International 10.1016/j.kint.2021.09.005. (In press).\n\nHeerspink, HJL; Jongs, N; Chertow, GM; Langkilde, AM; McMurray, JJV; Correa-Rotter, R; Rossing, P; ... DAPA-CKD Trial Committees and Investigators, .; + view all Heerspink, HJL; Jongs, N; Chertow, GM; Langkilde, AM; McMurray, JJV; Correa-Rotter, R; Rossing, P; Sjöström, CD; Stefansson, BV; Toto, RD; Wheeler, DC; Greene, T; DAPA-CKD Trial Committees and Investigators, .; - view fewer (2021) Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol , 9 (11) pp. 743-754. 10.1016/S2213-8587(21)00242-4.\n\nJardine, M; Zhou, Z; Lambers Heerspink, HJ; Hockham, C; Li, Q; Agarwal, R; Bakris, GL; ... Perkovic, V; + view all Jardine, M; Zhou, Z; Lambers Heerspink, HJ; Hockham, C; Li, Q; Agarwal, R; Bakris, GL; Cannon, CP; Charytan, DM; Greene, T; Levin, A; Li, J-W; Neuen, BL; Neal, B; Oh, R; Oshima, M; Pollock, C; Wheeler, DC; de Zeeuw, D; Zhang, H; Zinman, B; Mahaffey, KW; Perkovic, V; - view fewer (2021) Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis. Clinical Journal of the American Society of Nephrology , 16 (2) , Article 15260920. 10.2215/CJN.15260920.\n\nJongs, N; Greene, T; Chertow, GM; McMurray, JJV; Langkilde, AM; Correa-Rotter, R; Rossing, P; ... DAPA-CKD Trial Committees and Investigators, .; + view all Jongs, N; Greene, T; Chertow, GM; McMurray, JJV; Langkilde, AM; Correa-Rotter, R; Rossing, P; Sjöström, CD; Stefansson, BV; Toto, RD; Wheeler, DC; Heerspink, HJL; DAPA-CKD Trial Committees and Investigators, .; - view fewer (2021) Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes and Endocrinology , 9 (11) pp. 755-766. 10.1016/S2213-8587(21)00243-6.\n\nMcMurray, JJV; Wheeler, DC; Stefánsson, BV; Jongs, N; Postmus, D; Correa-Rotter, R; Chertow, GM; ... DAPA-CKD Trial Committees and Investigators; + view all McMurray, JJV; Wheeler, DC; Stefánsson, BV; Jongs, N; Postmus, D; Correa-Rotter, R; Chertow, GM; Greene, T; Held, C; Hou, FF; Mann, JFE; Rossing, P; Sjöström, CD; Toto, RD; Langkilde, AM; Heerspink, HJL; DAPA-CKD Trial Committees and Investigators; - view fewer (2021) Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease. Circulation , 143 (5) pp. 438-448. 10.1161/CIRCULATIONAHA.120.051675.\n\nNeuen, BL; Ohkuma, T; Neal, B; Matthews, DR; de Zeeuw, D; Mahaffey, KW; Fulcher, G; ... Wheeler, DC; + view all Neuen, BL; Ohkuma, T; Neal, B; Matthews, DR; de Zeeuw, D; Mahaffey, KW; Fulcher, G; Blais, J; Li MBiostat, Q; Jardine, MJ; Perkovic, V; Wheeler, DC; - view fewer (2021) Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program. American Journal of Kidney Diseases , 77 (1) 23-34.e1. 10.1053/j.ajkd.2020.06.018.\n\nSarraju, A; Li, J; Cannon, CP; Chang, TI; Agarwal, R; Bakris, G; Charytan, DM; ... Mahaffey, KW; + view all Sarraju, A; Li, J; Cannon, CP; Chang, TI; Agarwal, R; Bakris, G; Charytan, DM; de Zeeuw, D; Greene, T; Heerspink, HJL; Levin, A; Neal, B; Pollock, C; Wheeler, DC; Yavin, Y; Zhang, H; Zinman, B; Perkovic, V; Jardine, M; Mahaffey, KW; - view fewer (2021) Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes in Participants With Type 2 Diabetes and Chronic Kidney Disease According to History of Heart Failure: Results From the CREDENCE Trial. American Heart Journal , 233 pp. 141-148. 10.1016/j.ahj.2020.12.008.\n\nWheeler, DC; Jongs, N; Stefansson, BV; Chertow, GM; Greene, T; Hou, FF; Langkilde, AM; ... DAPA-CKD Trial Committees and Investigators; + view all Wheeler, DC; Jongs, N; Stefansson, BV; Chertow, GM; Greene, T; Hou, FF; Langkilde, AM; McMurray, JJV; Rossing, P; Nowicki, M; Wittmann, I; Correa-Rotter, R; Sjöström, CD; Toto, RD; Heerspink, HJL; DAPA-CKD Trial Committees and Investigators; - view fewer (2021) Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: A prespecified analysis of the DAPA-CKD trial. Nephrology Dialysis Transplantation 10.1093/ndt/gfab335. (In press).\n\nWheeler, DC; Stefansson, B; Jongs, N; Chertow, GM; Greene, T; Hou, FF; McMurray, JJ; ... Heerspink, HJL; + view all Wheeler, DC; Stefansson, B; Jongs, N; Chertow, GM; Greene, T; Hou, FF; McMurray, JJ; Correa-Rotter, R; Rossing, P; Toto, RD; Sjostrom, CD; Langkilde, AM; Heerspink, HJL; - view fewer (2021) Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes & Endocrinology , 9 (1) pp. 22-31. 10.1016/S2213-8587(20)30369-7.\n\nWheeler, DC; Toto, RD; Stefansson, BV; Jongs, N; Chertow, GM; Greene, T; Hou, FF; ... DAPA-CKD Trial Committees and Investigators; + view all Wheeler, DC; Toto, RD; Stefansson, BV; Jongs, N; Chertow, GM; Greene, T; Hou, FF; McMurray, JJV; Pecoits-Filho, R; Correa-Rotter, R; Rossing, P; Sjöström, CD; Umanath, K; Langkilde, AM; Heerspink, HJL; DAPA-CKD Trial Committees and Investigators; - view fewer (2021) A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy. Kidney International 10.1016/j.kint.2021.03.033. (In press).\n\nYe, N; Jardine, MJ; Oshima, M; Hockham, C; Heerspink, HJL; Agarwal, R; Bakris, G; ... Neuen, BL; + view all Ye, N; Jardine, MJ; Oshima, M; Hockham, C; Heerspink, HJL; Agarwal, R; Bakris, G; Schutte, AE; Arnott, C; Chang, TI; Górriz, JL; Cannon, CP; Charytan, DM; de Zeeuw, D; Levin, A; Mahaffey, KW; Neal, B; Pollock, C; Wheeler, DC; Di Tanna, GL; Cheng, H; Perkovic, V; Neuen, BL; - view fewer (2021) Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights from the CREDENCE Trial. Circulation , 143 (18) pp. 1735-1749. 10.1161/CIRCULATIONAHA.120.048740.\n\nBakris, G; Oshima, M; Mahaffey, KW; Agarwal, R; Cannon, CP; Capuano, G; Charytan, DM; ... Perkovic, V; + view all Bakris, G; Oshima, M; Mahaffey, KW; Agarwal, R; Cannon, CP; Capuano, G; Charytan, DM; de Zeeuw, D; Edwards, R; Greene, T; Heerspink, HJL; Levin, A; Neal, B; Oh, R; Pollock, C; Rosenthal, N; Wheeler, DC; Zhang, H; Zinman, B; Jardine, MJ; Perkovic, V; - view fewer (2020) Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m²: Subgroup Analysis of the Randomized CREDENCE Trial. Clinical Journal of the American Society of Nephrology 10.2215/CJN.10140620.\n\nCannon, CP; Perkovic, V; Agarwal, R; Baldassarre, J; Bakris, G; Charytan, DM; De Zeeuw, D; ... Mahaffey, KW; + view all Cannon, CP; Perkovic, V; Agarwal, R; Baldassarre, J; Bakris, G; Charytan, DM; De Zeeuw, D; Edwards, R; Greene, T; Heerspink, HJL; Jardine, MJ; Levin, A; Li, J-W; Neal, B; Pollock, C; Wheeler, DC; Zhang, H; Zinman, B; Mahaffey, KW; - view fewer (2020) Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c <7%: Results From the CREDENCE Trial. Circulation , 141 (5) pp. 407-410. 10.1161/CIRCULATIONAHA.119.044359.\n\nGonzalez, AM; Gutman, T; Lopez-Vargas, P; Anumudu, S; Arce, CM; Craig, JC; Dunn, L; ... Tong, A; + view all Gonzalez, AM; Gutman, T; Lopez-Vargas, P; Anumudu, S; Arce, CM; Craig, JC; Dunn, L; Eckardt, K-U; Harris, T; Levey, AS; Lightstone, L; Scholes-Robertson, N; Shen, JI; Teixeira-Pinto, A; Wheeler, DC; White, D; Wilkie, M; Jadoul, M; Winkelmayer, WC; Tong, A; - view fewer (2020) Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study. American Journal of Kidney Diseases , 76 (5) pp. 679-689. 10.1053/j.ajkd.2020.03.022.\n\nJardine, MJ; Zhou, Z; Mahaffey, KW; Oshima, M; Agarwal, R; Bakris, G; Bajaj, HS; ... CREDENCE Study Investigators; + view all Jardine, MJ; Zhou, Z; Mahaffey, KW; Oshima, M; Agarwal, R; Bakris, G; Bajaj, HS; Bull, S; Cannon, CP; Charytan, DM; de Zeeuw, D; Di Tanna, GL; Greene, T; Heerspink, HJL; Levin, A; Neal, B; Pollock, C; Qiu, R; Sun, T; Wheeler, DC; Zhang, H; Zinman, B; Rosenthal, N; Perkovic, V; CREDENCE Study Investigators; - view fewer (2020) Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial. Journal of the American Society of Nephrology (JASN) , 31 (5) pp. 1128-1139. 10.1681/ASN.2019111168.\n\nLevin, A; Agarwal, R; Herrington, WG; Heerspink, HL; Mann, JFE; Shahinfar, S; Tuttle, KR; ... participant authors of the International Society of Nephrology’s; + view all Levin, A; Agarwal, R; Herrington, WG; Heerspink, HL; Mann, JFE; Shahinfar, S; Tuttle, KR; Donner, J-A; Jha, V; Nangaku, M; de Zeeuw, D; Jardine, MJ; Mahaffey, KW; Thompson, AM; Beaucage, M; Chong, K; Roberts, GV; Sunwold, D; Vorster, H; Warren, M; Damster, S; Malik, C; Perkovic, V; participant authors of the International Society of Nephrology’s; - view fewer (2020) International consensus definitions of clinical trial outcomes for kidney failure: 2020. Kidney International , 98 (4) pp. 849-859. 10.1016/j.kint.2020.07.013.\n\nLevin, A; Perkovic, V; Wheeler, DC; Hantel, S; George, JT; von Eynatten, M; Koitka-Weber, A; ... EMPA-REG OUTCOME Investigators; + view all Levin, A; Perkovic, V; Wheeler, DC; Hantel, S; George, JT; von Eynatten, M; Koitka-Weber, A; Wanner, C; EMPA-REG OUTCOME Investigators; - view fewer (2020) Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Multinational Trial. Clinical Journal of the American Society of Nephrology , 15 (10) pp. 1433-1444. 10.2215/CJN.14901219.\n\nMacdougall, IC; Bhandari, S; White, C; Anker, SD; Farrington, K; Kalra, PA; Mark, PB; ... PIVOTAL investigators and committees; + view all Macdougall, IC; Bhandari, S; White, C; Anker, SD; Farrington, K; Kalra, PA; Mark, PB; McMurray, JJV; Reid, C; Robertson, M; Tomson, CRV; Wheeler, DC; Winearls, CG; Ford, I; PIVOTAL investigators and committees; - view fewer (2020) Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial. Journal of the American Society of Nephrology (JASN) , 31 (5) pp. 1118-1127. 10.1681/ASN.2019090972.\n\nOshima, M; Jardine, MJ; Agarwal, R; Bakris, G; Cannon, CP; Charytan, DM; de Zeeuw, D; ... Heerspink, HJL; + view all Oshima, M; Jardine, MJ; Agarwal, R; Bakris, G; Cannon, CP; Charytan, DM; de Zeeuw, D; Edwards, R; Greene, T; Levin, A; Lim, SK; Mahaffey, KW; Neal, B; Pollock, C; Rosenthal, N; Wheeler, DC; Zhang, H; Zinman, B; Perkovic, V; Heerspink, HJL; - view fewer (2020) Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice. Kidney International 10.1016/j.kint.2020.10.042. (In press).\n\nOshima, M; Neuen, BL; Jardine, MJ; Bakris, G; Edwards, R; Levin, A; Mahaffey, KW; ... Heerspink, HJL; + view all Oshima, M; Neuen, BL; Jardine, MJ; Bakris, G; Edwards, R; Levin, A; Mahaffey, KW; Neal, B; Pollock, C; Rosenthal, N; Wada, T; Wheeler, DC; Perkovic, V; Heerspink, HJL; - view fewer (2020) Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial. The Lancet Diabetes & Endocrinology , 8 (11) pp. 903-914. 10.1016/S2213-8587(20)30300-4.\n\nOshima, M; Neuen, BL; Li, J; Perkovic, V; Charytan, DM; de Zeeuw, D; Edwards, R; ... Heerspink, HJL; + view all Oshima, M; Neuen, BL; Li, J; Perkovic, V; Charytan, DM; de Zeeuw, D; Edwards, R; Greene, T; Levin, A; Mahaffey, KW; De Nicola, L; Pollock, C; Rosenthal, N; Wheeler, DC; Jardine, MJ; Heerspink, HJL; - view fewer (2020) Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A PostHoc Analysis from the CREDENCE Trial. Journal of the American Society of Nephrology 10.1681/ASN.2020050723. (In press).\n\nTong, A; Levey, AS; Eckardt, K-U; Anumudu, S; Arce, CM; Baumgart, A; Dunn, L; ... Winkelmayer, WC; + view all Tong, A; Levey, AS; Eckardt, K-U; Anumudu, S; Arce, CM; Baumgart, A; Dunn, L; Gutman, T; Harris, T; Lightstone, L; Scholes-Robertson, N; Shen, JI; Wheeler, DC; White, DM; Wilkie, M; Craig, JC; Jadoul, M; Winkelmayer, WC; - view fewer (2020) Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health. Clinical Journal of the American Society of Nephrology , 15 (7) pp. 937-948. 10.2215/CJN.00900120.\n\nWheeler, DC; James, J; Patel, D; Viljoen, A; Ali, A; Evans, M; Fernando, K; ... as part of the Improving Diabetes Steering Committee, .; + view all Wheeler, DC; James, J; Patel, D; Viljoen, A; Ali, A; Evans, M; Fernando, K; Hicks, D; Milne, N; Newland-Jones, P; Wilding, J; as part of the Improving Diabetes Steering Committee, .; - view fewer (2020) SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes. Diabetes Therapy 10.1007/s13300-020-00930-x. (In press).\n\nInker, LA; Grams, ME; Levey, AS; Coresh, J; Cirillo, M; Collins, JF; Gansevoort, RT; ... Surapaneni, A; + view all Inker, LA; Grams, ME; Levey, AS; Coresh, J; Cirillo, M; Collins, JF; Gansevoort, RT; Gutierrez, OM; Hamano, T; Heine, GH; Ishikawa, S; Jee, SH; Kronenberg, F; Landray, MJ; Miura, K; Nadkarni, GN; Peralta, CA; Rothenbacher, D; Schaeffner, E; Sedaghat, S; Shlipak, MG; Zhang, L; van Zuilen, AD; Hallan, S; Kovesdy, CP; Woodward, M; Levin, A; Astor, B; Appel, LJ; Greene, T; Chen, TK; Chalmers, J; Arima, H; Perkovic, V; Yatsuya, H; Tamakoshi, K; Li, Y; Hirakawa, Y; Matsushita, K; Grams, M; Sang, Y; Polldnghorne, K; Chadban, S; Atkins, R; Djurdjev, O; Liu, L; Zhao, M-H; Wang, F; Wang, J; Ebert, N; Martus, P; Tang, M; Heine, G; Emrich, I; Seiler, S; Zawada, A; Nally, J; Navaneethan, SD; Schold, JD; Zhao, M; Sarnak, MJ; Katz, R; Hiramoto, J; Iso, H; Yamagishi, K; Umesawa, M; Murald, I; Fukagawa, M; Maruyama, S; Hasegawa, T; Fujii, N; Wheeler, DC; Emberson, J; Townend, J; Landray, M; Brenner, H; Schottker, B; Saum, K-U; Fox, C; Hwang, S-J; Kottgen, A; Schneider, MP; Eckardt, K-U; Green, JA; Kirchner, HL; Chang, AR; Ho, K; Ito, S; Miyazaki, M; Nakayama, M; Yamada, G; Irie, F; Sairenchi, T; Yano, Y; Kotani, K; Nakamura, T; Kimm, H; Mok, Y; Chodick, G; Shalev, V; Wetzels, JFM; Blankestijn, PJ; van den Brand, JA; Sarnak, M; Peralta, C; Kollerits, B; Ritz, E; Nitsch, D; Roderick, P; Fletcher, A; Bottinger, E; Ellis, SB; Nadukuru, R; Ueshima, H; Okayama, A; Miura, K; Tanaka, S; Okamura, T; Kadota, A; Kenealy, T; Elley, CR; Drury, PL; Ohkubo, T; Asayama, K; Metold, H; Kikuya, M; Nelson, RG; Knowler, WC; Bakker, SJL; Hak, E; Heerspink, HJL; Brunskill, NJ; Major, RW; Shepherd, D; Medcalf, JF; Bernardo, R; Jassal, SK; Bergstrom, J; Ix, JH; Barrett-Connor, E; Kalantar-Zadeh, K; Sumida, K; Muntner, P; Warnock, D; McClellan, W; de Zeeuw, D; Brenner, B; Ikram, MA; Hoorn, EJ; Dehghan, A; Carrero, JJ; Gasparini, A; Wettermark, B; Elinder, C-G; Wong, TY; Sabanayagam, C; Cheng, C-Y; Sokor, RBBMA; Visseren, FLJ; Evans, M; Segelmark, M; Stendahl, M; Schon, S; Tangri, N; Sud, M; Naimark, DM; Wen, C-P; Tsao, C-K; Tsai, M-K; Chen, C-H; Konta, T; Hirayama, A; Ichikawa, K; Lannfelt, L; Larsson, A; Arnlov, J; Bilo, HJG; Landman, GWD; van Hateren, KJJ; Kleefstra, N; Hallan, S; Ballew, SH; Chen, J; Kwak, L; Surapaneni, A; - view fewer (2019) Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium. American Journal of Kidney Diseases , 73 (2) pp. 206-217. 10.1053/j.ajkd.2018.08.013.\n\nLange Neuen, B; Young, T; Heerspink, H; Neal, B; Perkovic, V; Billot, L; Mahaffey, KW; ... Jardine, MJ; + view all Lange Neuen, B; Young, T; Heerspink, H; Neal, B; Perkovic, V; Billot, L; Mahaffey, KW; Charytan, DM; Wheeler, DC; Arnott, C; Bompoint, S; Levin, A; Jardine, MJ; - view fewer (2019) SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. The Lancet Diabetes and Endocrinology , 7 (11) pp. 845-854. 10.1016/S2213-8587(19)30256-6.\n\nMahaffey, KW; Jardine, M; Bompoint, S; Cannon, C; Bruce, N; Herspink, LHJ; Charytan, D; ... Perkovic, V; + view all Mahaffey, KW; Jardine, M; Bompoint, S; Cannon, C; Bruce, N; Herspink, LHJ; Charytan, D; Edwards, R; Bull, S; Capuano, G; De Zeeuw, D; Levin, A; Pollock, C; Wheeler, DC; Yavin, Y; Zinman, B; Rosenthal, N; Brenner, BM; Perkovic, V; - view fewer (2019) Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results From the Randomized CREDENCE Trial. Circulation , 140 (9) pp. 739-750. 10.1161/CIRCULATIONAHA.119.042007.\n\nSchlackow, I; Kent, S; Herrington, W; Emberson, J; Haynes, R; Reith, C; Collins, R; ... Tomson, C; + view all Schlackow, I; Kent, S; Herrington, W; Emberson, J; Haynes, R; Reith, C; Collins, R; Landray, MJ; Gray, A; Baigent, C; Mihaylova, B; Baxter, A; Young, A; Hill, M; Knott, C; Cass, A; Feldt-Rasmussen, B; Fellstrom, B; Grobbee, DE; Gronhagen-Riska, C; Haas, M; Holdaas, H; Hooi, LS; Jiang, L; Kasiske, B; Krairittichai, U; Levin, A; Massy, ZA; Tesar, V; Walker, R; Wanner, C; Wheeler, DC; Wiecek, A; Dasgupta, T; Herrington, W; Lewis, D; Mafham, M; Majoni, W; Reith, C; Emberson, J; Parish, S; Simpson, D; Strony, J; Musliner, T; Agodoa, L; Armitage, J; Chen, Z; Craig, J; de Zeeuw, D; Gaziano, JM; Grimm, R; Krane, V; Neal, B; Ophascharoensuk, V; Pedersen, T; Sleight, P; Tobert, J; Tomson, C; - view fewer (2019) Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease. Kidney International , 96 (1) pp. 170-179. 10.1016/j.kint.2019.01.028.\n\nViecelli, AK; Polkinghorne, KR; Pascoe, EM; Paul-Brent, P-A; Hawley, CM; Badve, SV; Cass, A; ... Wheeler, DC; + view all Viecelli, AK; Polkinghorne, KR; Pascoe, EM; Paul-Brent, P-A; Hawley, CM; Badve, SV; Cass, A; Hooi, L-S; Kerr, PG; Mori, TA; Ong, L-M; Voss, D; Johnson, DW; Irish, AB; Peh, CA; Beller, E; Dogra, S; Gracey, D; Haluszkiewicz, E; Hawley, C; Hutchison, C; Irish, A; Kerr, P; Mather, A; McDonald, S; McIntyre, C; Mori, T; Pascoe, E; Polkinghorne, K; Robertson, A; Rosman, J; Forbes, A; Levin, A; Wheeler, DC; - view fewer (2019) Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial. PLOS ONE , 14 (3) , Article e0213274. 10.1371/journal.pone.0213274.\n\nWang, AY-M; Akizawa, T; Bavanandan, S; Hamano, T; Liew, A; Lu, K-C; Lumlertgul, D; ... Fukagawa, M; + view all Wang, AY-M; Akizawa, T; Bavanandan, S; Hamano, T; Liew, A; Lu, K-C; Lumlertgul, D; Oh, K-H; Zhao, M-H; Fung, SK-S; Obi, Y; Sumida, K; Choong, LHL; Goh, BL; Hao, C-M; Kwon, Y-J; Tarng, D-C; Zuo, L; Wheeler, DC; Tsukamoto, Y; Fukagawa, M; - view fewer (2019) 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report. Kidney International Reports , 4 (11) pp. 1523-1537. 10.1016/j.ekir.2019.09.007.\n\nEckardt, K-U; Bansal, N; Coresh, J; Evans, M; Grams, ME; Herzog, CA; James, MT; ... Conference Participants, .; + view all Eckardt, K-U; Bansal, N; Coresh, J; Evans, M; Grams, ME; Herzog, CA; James, MT; Heerspink, HJL; Pollock, CA; Stevens, PE; Tamura, MK; Tonelli, MA; Wheeler, DC; Winkelmayer, WC; Cheung, M; Hemmelgarn, BR; Conference Participants, .; - view fewer (2018) Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International 10.1016/j.kint.2018.02.006. (In press).\n\nEvans, M; Grams, ME; Sang, Y; Astor, BC; Blankestijn, PJ; Brunskill, NJ; Collins, JF; ... Wheeler, DC; + view all Evans, M; Grams, ME; Sang, Y; Astor, BC; Blankestijn, PJ; Brunskill, NJ; Collins, JF; Kalra, PA; Kovesdy, CP; Levin, A; Mark, PB; Moranne, O; Rao, P; Rios, PG; Schneider, MP; Shalev, V; Zhang, H; Chang, AR; Gansevoort, RT; Matsushita, K; Zhang, L; Eckardt, KU; Hemmelgarn, B; Wheeler, DC; - view fewer (2018) Risk Factors for Prognosis in Patients With Severely Decreased GFR. Kidney International Reports , 3 (3) pp. 625-637. 10.1016/j.ekir.2018.01.002.\n\nMarthi, A; Donovan, K; Haynes, R; Wheeler, DC; Baignent, C; Rooney, CM; Landray, MJ; ... Herrington, W; + view all Marthi, A; Donovan, K; Haynes, R; Wheeler, DC; Baignent, C; Rooney, CM; Landray, MJ; Moe, SM; Yang, J; Holland, L; Giuseppe, RD; Bouma-deKrijger, A; Mihaylova, B; Herrington, W; - view fewer (2018) Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis. Journal of the American Society of Nephrology , 29 (7) pp. 2015-2027. 10.1681/ASN.2017121334.\n\nO'Lone, E; Viecelli, AK; Craig, JC; Tong, A; Sautenet, B; Roy, D; Herrington, WG; ... Wheeler, DC; + view all O'Lone, E; Viecelli, AK; Craig, JC; Tong, A; Sautenet, B; Roy, D; Herrington, WG; Herzog, CA; Jafar, T; Jardine, M; Krane, V; Levin, A; Malyszko, J; Rocco, MV; Strippoli, G; Tonelli, M; Wang, AYM; Wanner, C; Zannad, F; Winkelmayer, WC; Webster, AC; Wheeler, DC; - view fewer (2018) Cardiovascular Outcomes Reported in Hemodialysis Trials. Journal of the American College of Cardiology , 71 (24) pp. 2802-2810. 10.1016/j.jacc.2018.04.012.\n\nSautenet, B; Tong, A; Williams, G; Hemmelgarn, BR; Manns, B; Wheeler, DC; Tugwell, P; ... Craig, JC; + view all Sautenet, B; Tong, A; Williams, G; Hemmelgarn, BR; Manns, B; Wheeler, DC; Tugwell, P; Van Biesen, W; Winkelmayer, WC; Crowe, S; Harris, T; Evangelidis, N; Hawley, CM; Pollack, C; Johnson, DW; Polkinghorne, KR; Howard, K; Gallagher, MP; Kerr, P; McDonald, SP; Ju, A; Craig, JC; - view fewer (2018) Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review. American Journal of Kidney Diseases , 72 (1) pp. 62-74. 10.1053/j.ajkd.2017.11.010.\n\nTong, A; Crowe, S; Gill, JS; Harris, T; Hemmelgarn, B; Manns, B; Tugwell, P; ... Craig, J; + view all Tong, A; Crowe, S; Gill, JS; Harris, T; Hemmelgarn, B; Manns, B; Tugwell, P; Van Biesen, W; Wang, YM; Wheeler, DC; Winkelmayer, W; Gutman, T; Ju, A; O'Lone, E; Viecelli, A; Craig, J; - view fewer (2018) Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study. BMJ Open , 8 (4) , Article e021198. 10.1136/bmjopen-2017-021198.\n\nTong, A; Manns, B; Wang, AYM; Hemmelgarn, B; Wheeler, DC; Gill, J; Tugwell, P; ... Craig, JC; + view all Tong, A; Manns, B; Wang, AYM; Hemmelgarn, B; Wheeler, DC; Gill, J; Tugwell, P; Pecoits-Filho, R; Crowe, S; Harris, T; Van Biesen, WV; Winkelmayer, W; Levin, A; Thompson, A; Perkovic, V; Ju, A; Gutman, T; Bernier-Jean, A; Viecelli, A; O'Lone, E; Shen, J; Josephson, MA; Cho, Y; Sautenet, B; Tonelli, M; Craig, JC; - view fewer (2018) Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney International , 94 (6) pp. 1053-1068. 10.1016/j.kint.2018.08.018.\n\nVerberne, WR; Das-Gupta, Z; Allegretti, AS; Bart, HAJ; van Biesen, W; García-García, G; Gibbons, E; ... Bos, WJW; + view all Verberne, WR; Das-Gupta, Z; Allegretti, AS; Bart, HAJ; van Biesen, W; García-García, G; Gibbons, E; Parra, E; Hemmelder, MH; Jager, KJ; Ketteler, M; Roberts, C; Al Rohani, M; Salt, MJ; Stopper, A; Terkivatan, T; Tuttle, KR; Yang, C-W; Wheeler, DC; Bos, WJW; - view fewer (2018) Development of an International Standard Set of Value-Based Outcome Measures for Patients With Chronic Kidney Disease: A Report of the International Consortium for Health Outcomes Measurement (ICHOM) CKD Working Group. American Journal of Kidney Diseases 10.1053/j.ajkd.2018.10.007. (In press).\n\nWheeler, DC; Haynes, R; Judge, PK; Staplin, N; Herrington, WG; Storey, BC; Bethel, A; ... Baigent, C; + view all Wheeler, DC; Haynes, R; Judge, PK; Staplin, N; Herrington, WG; Storey, BC; Bethel, A; Bowman, L; Brunskill, N; Cockwell, P; Hill, M; Kalra, PA; McMurray, JJV; Taal, M; Wheeler, DC; Landray, MJ; Baigent, C; - view fewer (2018) Effects of Sacubitril/Valsartan versus Irbesartan in patients with chronic kidney disease: a randomised double-blind trial. Circulation , 138 (15) 10.1161/CIRCULATIONAHA.118.034818.\n\nWheeler, DC; Jardine, MJ; Mahaffey, KW; Neal, B; Agarwal, R; Bakris, G; Brenner, BM; ... Perkovic, V; + view all Wheeler, DC; Jardine, MJ; Mahaffey, KW; Neal, B; Agarwal, R; Bakris, G; Brenner, BM; Bull, S; Cannon, CP; Charytan, DM; De Zeeuw, D; Edwards, R; Greene, T; Heerspink, HJL; Levin, A; Pollock, C; Xie, J; Zinman, B; Desai, M; Perkovic, V; - view fewer (2018) The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale and design. American Journal of Nephrology , 46 (6) pp. 462-472. 10.1159/000484633.\n\nWheeler, DC; Kovesdy, C; Matsushita, K; Sang, Y; Brunskill, NJ; Carrero, JJ; Chodick, G; ... Grams, ME; + view all Wheeler, DC; Kovesdy, C; Matsushita, K; Sang, Y; Brunskill, NJ; Carrero, JJ; Chodick, G; Hasegawa, T; Heerspoink, H; Kirayama, A; Landman, GWD; Coresh, J; Hallan, S; Shalev, V; Grams, ME; - view fewer (2018) Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis. European Heart Journal , 39 (17) pp. 1535-1542. 10.1093/eurheartj/ehy100.\n\nBaigent, C; Herrington, WG; Coresh, J; Landray, MJ; Levin, A; Perkovic, V; Pfeffer, MA; ... McMurray, JJV; + view all Baigent, C; Herrington, WG; Coresh, J; Landray, MJ; Levin, A; Perkovic, V; Pfeffer, MA; Rossing, P; Walsh, M; Wanner, C; Wheeler, DC; Winkelmayer, WC; McMurray, JJV; - view fewer (2017) Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International , 92 (2) pp. 297-305. 10.1016/j.kint.2017.04.019.\n\nBello, AK; Alrukhaimi, M; Ashuntantang, GE; Basnet, S; Rotter, RC; Douthat, WG; Kazancioglu, R; ... Moe, O; + view all Bello, AK; Alrukhaimi, M; Ashuntantang, GE; Basnet, S; Rotter, RC; Douthat, WG; Kazancioglu, R; Koettgen, A; Nangaku, M; Powe, NR; White, SL; Wheeler, DC; Moe, O; - view fewer (2017) Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. [Review]. Kidney International Supplements , 7 (2) pp. 122-129. 10.1016/j.kisu.2017.07.007.\n\nEvangelidis, N; Tong, A; Manns, B; Hemmelgarn, B; Wheeler, DC; Tugwell, P; Crowe, S; ... Craig, JC; + view all Evangelidis, N; Tong, A; Manns, B; Hemmelgarn, B; Wheeler, DC; Tugwell, P; Crowe, S; Harris, T; Van Biesen, W; Winkelmayer, WC; Sautenet, B; O'Donoghue, D; Tam-Tham, H; Youssouf, S; Mandayam, S; Ju, A; Hawley, C; Pollock, C; Harris, DC; Johnson, DW; Rifkin, DE; Tentori, F; Agar, J; Polkinghorne, KR; Gallagher, M; Kerr, PG; McDonald, SP; Howard, K; Howell, M; Craig, JC; - view fewer (2017) Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey. American Journal of Kidney Diseases , 70 (4) pp. 464-475. 10.1053/j.ajkd.2016.11.029.\n\nHayer, MK; Edwards, NC; Slinn, G; Moody, WE; Steeds, RP; Ferro, CJ; Price, AM; ... Townend, JN; + view all Hayer, MK; Edwards, NC; Slinn, G; Moody, WE; Steeds, RP; Ferro, CJ; Price, AM; Andujar, C; Dutton, M; Webster, R; Webb, DJ; Semple, S; MacIntyre, I; Melville, V; Wilkinson, IB; Hiemstra, TF; Wheeler, DC; Herrey, A; Grant, M; Mehta, S; Ives, N; Townend, JN; - view fewer (2017) A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial. American Heart Journal , 191 (C) pp. 37-46. 10.1016/j.ahj.2017.05.008.\n\nLevin, A; Tonelli, M; Bonventre, J; Coresh, J; Donner, J-A; Fogo, AB; Fox, CS; ... ISN Global Kidney Health Summit participants; + view all Levin, A; Tonelli, M; Bonventre, J; Coresh, J; Donner, J-A; Fogo, AB; Fox, CS; Gansevoort, RT; Heerspink, HJL; Jardine, M; Kasiske, B; Köttgen, A; Kretzler, M; Levey, AS; Luyckx, VA; Mehta, R; Moe, O; Obrador, G; Pannu, N; Parikh, CR; Perkovic, V; Pollock, C; Stenvinkel, P; Tuttle, KR; Wheeler, DC; Eckardt, K-U; ISN Global Kidney Health Summit participants; - view fewer (2017) Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. The Lancet , 390 (10105) pp. 1888-1917. 10.1016/S0140-6736(17)30788-2.\n\nMafham, MM; Staplin, N; Emberson, J; Haynes, R; Herrington, W; Reith, C; Wanner, C; ... SHARP Collaborative Group, .; + view all Mafham, MM; Staplin, N; Emberson, J; Haynes, R; Herrington, W; Reith, C; Wanner, C; Walker, R; Cass, A; Levin, A; Fellström, B; Jiang, L; Holdaas, H; Kasiske, B; Wheeler, DC; Landray, MJ; Baigent, C; SHARP Collaborative Group, .; - view fewer (2017) Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection. Nephrology Dialysis Transplantation 10.1093/ndt/gfw396. (In press).\n\nTong, A; Craig, JC; Nagler, EV; Van Biesen, W; Manns, B; Hemmelgarn, B; Wheeler, DC; ... Zoccali, C; + view all Tong, A; Craig, JC; Nagler, EV; Van Biesen, W; Manns, B; Hemmelgarn, B; Wheeler, DC; Gill, J; Tugwell, P; Pecoits-Filho, R; Crowe, S; Harris, T; Winkelmayer, WC; Wang, AYM; Fox, J; Abramowicz, D; Cannata-Andia, J; Covic, A; Del Vecchio, L; Fouque, D; Heimburger, O; Jager, K; Lindley, E; Marti-Monros, A; Oberbauer, R; Rychlik, I; Spasovski, G; Tattersall, J; Vanholder, R; Wanner, C; Whithers, W; Wiecek, A; Zoccali, C; - view fewer (2017) Composing a new song for trials: the Standardized Outcomes in Nephrology (SONG) initiative. Nephrology Dialysis Transplantation , 32 (12) pp. 1963-1966. 10.1093/ndt/gfx288.\n\nWheeler, DC; Bello, AK; Alkhaim, M; Ashuntantang, G; Basnet, S; Rotter, RC; Douthat, W; ... Moe, O; + view all Wheeler, DC; Bello, AK; Alkhaim, M; Ashuntantang, G; Basnet, S; Rotter, RC; Douthat, W; Kazancioglu, R; Kottgen, A; Nangaku, M; Powe, N; White, SL; Moe, O; - view fewer (2017) Complications of CKD: current state, knowledge gaps, and strategy for action. Kidney International Supplements , 7 (2) pp. 122-129. 10.1016/j.kisu.2017.07.007.\n\nWheeler, DC; Lv, J; Zhang, H; Wong, MG; Jardine, MJ; Hladunewich, M; Jha, V; ... Perkovic, V; + view all Wheeler, DC; Lv, J; Zhang, H; Wong, MG; Jardine, MJ; Hladunewich, M; Jha, V; Monaghan, H; Zhoa, M; Barbour, S; Reich, H; Glassock, R; Levin, A; Woodward, M; Billot, L; Chan, TM; Liu, ZH; Johnson, DW; Cass, A; Feehally, J; Floege, J; Remuzzi, G; Wu, Y; Agarwal, R; Wang, HJ; Perkovic, V; - view fewer (2017) Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. JAMA - Journal of the American Medical Association , 318 (5) pp. 432-442. 10.1001/jama.2017.9362.\n\nWheeler, DC; Tong, A; Wolfgang, C; van Biesen5, W; Tugwell, P; Manns, B; Hemmelgarn, B; ... Craig, JC; + view all Wheeler, DC; Tong, A; Wolfgang, C; van Biesen5, W; Tugwell, P; Manns, B; Hemmelgarn, B; Harris, T; Crowe, S; Ju, A; O'Lone, E; Evangelidis, N; Craig, JC; - view fewer (2017) Nephrologists' perspectives on defining and applying patient-centered outcomes in hemodialysis. Clinical Journal of the American Society of Nephrology , 12 (3) pp. 454-466. 10.2215/​CJN.08370816.\n\nEvangelidis, N; Tong, A; Manns, B; Hemmelgarn, B; Wheeler, D; Tugwell, P; Crowe, S; ... Craig, J; + view all Evangelidis, N; Tong, A; Manns, B; Hemmelgarn, B; Wheeler, D; Tugwell, P; Crowe, S; Harris, T; Van Biesen, W; Winkelmayer, W; Sautenet, B; O'Donaghue, D; Tam-Tham, H; Youssouf, S; Mandayam, S; Ju, A; Hawley, C; Pollock, C; Harris, D; Johnson, D; Rifkin, D; Tentori, F; Agar, J; Polkinghorne, K; Gallagher, M; Kerr, P; Mcdonald, S; Howell, M; Craig, J; - view fewer (2016) Developing a Set of Core Outcomes for Trials in Haemodialysis: An International Delphi Survey. In: (Proceedings) The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, 17–21 September 2016, Perth Convention and Exhibition Centre, Western Australia. (pp. p. 119). Wiley-Blackwell\n\nHerrington, W; Staplin, N; Judge, PK; Mafham, M; Emberson, J; Haynes, R; Wheeler, DC; ... SHARP Collaborative Group, .; + view all Herrington, W; Staplin, N; Judge, PK; Mafham, M; Emberson, J; Haynes, R; Wheeler, DC; Walker, R; Tomson, C; Agodoa, L; Wiecek, A; Lewington, S; Reith, CA; Landray, MJ; Baigent, C; SHARP Collaborative Group, .; - view fewer (2016) Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease. Hypertension , 69 (2) pp. 314-322. 10.1161/HYPERTENSIONAHA.116.08386.\n\nJha, V; Arici, M; Collins, AJ; Garcia-Garcia, G; Hemmelgarn, BR; Jafar, TH; Pecoits-Filho, R; ... Conference Participants; + view all Jha, V; Arici, M; Collins, AJ; Garcia-Garcia, G; Hemmelgarn, BR; Jafar, TH; Pecoits-Filho, R; Sola, L; Swanepoel, CR; Tchokhonelidze, I; Wang, AY; Kasiske, BL; Wheeler, DC; Spasovski, G; Conference Participants; - view fewer (2016) Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) Controversies Conference. Kidney International , 90 (6) pp. 1164-1174. 10.1016/j.kint.2016.09.009.\n\nJudge, PK; Haynes, R; Herrington, WG; Storey, BC; Staplin, N; Bethel, A; Bowman, L; ... Baigent, C; + view all Judge, PK; Haynes, R; Herrington, WG; Storey, BC; Staplin, N; Bethel, A; Bowman, L; Brunskill, N; Cockwell, P; Dayanandan, R; Hill, M; Kalra, PA; McMurray, JJ; Taal, M; Wheeler, DC; Landray, MJ; Baigent, C; - view fewer (2016) Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data. Nephrology Dialysis Transplantation , 32 (12) pp. 2043-2051. 10.1093/ndt/gfw321.\n\nMann, MC; Exner, DV; Hemmelgarn, BR; Hanley, DA; Turin, TC; MacRae, JM; Wheeler, DC; ... Ahmed, SB; + view all Mann, MC; Exner, DV; Hemmelgarn, BR; Hanley, DA; Turin, TC; MacRae, JM; Wheeler, DC; Sola, DY; Ramesh, S; Ahmed, SB; - view fewer (2016) The VITAH Trial-Vitamin D Supplementation and Cardiac Autonomic Tone in Patients with End-Stage Kidney Disease on Hemodialysis: A Blinded, Randomized Controlled Trial. Nutrients , 8 (10) , Article 608. 10.3390/nu8100608.\n\nParfrey, PS; Block, GA; Correa-Rotter, R; Drueke, TB; Floege, J; Herzog, CA; London, GM; ... Chertow, GM; + view all Parfrey, PS; Block, GA; Correa-Rotter, R; Drueke, TB; Floege, J; Herzog, CA; London, GM; Mahaffey, KW; Moe, SM; Wheeler, DC; Chertow, GM; - view fewer (2016) Lessons learned from EVOLVE for the planning of future global randomized trials in chronic kidney disease. Clinical Journal of the American Society of Nephrology , 11 (3) pp. 539-546. 10.2215/CJN.06370615.\n\nPerkovic, V; Agarwal, R; Fioretto, P; Hemmelgarn, BR; Levin, A; Thomas, MC; Wanner, C; ... Conference Participants; + view all Perkovic, V; Agarwal, R; Fioretto, P; Hemmelgarn, BR; Levin, A; Thomas, MC; Wanner, C; Kasiske, BL; Wheeler, DC; Groop, PH; Conference Participants; - view fewer (2016) Management of patients with diabetes and CKD: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) Controversies Conference. Kidney International , 90 (6) pp. 1175-1183. 10.1016/j.kint.2016.09.010.\n\nStaplin, N; Haynes, R; Herrington, WG; Reith, C; Cass, A; Fellström, B; Jiang, L; ... SHARP Collaborative Group, .; + view all Staplin, N; Haynes, R; Herrington, WG; Reith, C; Cass, A; Fellström, B; Jiang, L; Kasiske, BL; Krane, V; Levin, A; Walker, R; Wanner, C; Wheeler, DC; Landray, MJ; Baigent, C; Emberson, J; SHARP Collaborative Group, .; - view fewer (2016) Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP). American Journal of Kidney Diseases , 68 (3) pp. 371-380. 10.1053/j.ajkd.2016.02.052.\n\nTong, A; Budde, K; Gill, J; Josephson, MA; Marson, L; Pruett, TL; Reese, PP; ... Chapman, JR; + view all Tong, A; Budde, K; Gill, J; Josephson, MA; Marson, L; Pruett, TL; Reese, PP; Rosenbloom, D; Rostaing, L; Warrens, AN; Wong, G; Craig, JC; Crowe, S; Harris, T; Hemmelgarn, B; Manns, B; Tugwell, P; Van Biesen, W; Wheeler, DC; Winkelmayer, WC; Evangelidis, N; Sautenet, B; Howell, M; Chapman, JR; - view fewer (2016) Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation. Transplantation Direct , 2 (6) , Article e79. 10.1097/TXD.0000000000000593.\n\nTong, A; Manns, B; Hemmelgarn, B; Wheeler, DC; Evangelidis, N; Tugwell, P; Crowe, S; ... SONG-HD Investigators, .; + view all Tong, A; Manns, B; Hemmelgarn, B; Wheeler, DC; Evangelidis, N; Tugwell, P; Crowe, S; Van Biesen, W; Winkelmayer, WC; O'Donoghue, D; Tam-Tham, H; Shen, JI; Pinter, J; Larkins, N; Youssouf, S; Mandayam, S; Ju, A; Craig, JC; SONG-HD Investigators, .; - view fewer (2016) Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop. American Journal of Kidney Diseases , 69 (1) pp. 97-107. 10.1053/j.ajkd.2016.05.022.\n\nTong, A; Samuel, S; Zappitelli, M; Dart, A; Furth, S; Eddy, A; Groothoff, J; ... Craig, JC; + view all Tong, A; Samuel, S; Zappitelli, M; Dart, A; Furth, S; Eddy, A; Groothoff, J; Webb, NJA; Yap, H-K; Bockenhauer, D; Sinha, A; Alexander, SI; Goldstein, SL; Gipson, DS; Hanson, CS; Evangelidis, N; Crowe, S; Harris, T; Hemmelgarn, BR; Manns, B; Gill, J; Tugwell, P; Van Biesen, W; Wheeler, DC; Winkelmayer, WC; Craig, JC; - view fewer (2016) Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease. Trials , 17 , Article 401. 10.1186/s13063-016-1528-5.\n\nTomlinson, JAP; Caplin, BD; Boruc, O; Bruce-Cobbold, C; Cutillas, P; Dormann, D; Faull, P; ... Leiper, J; + view all Tomlinson, JAP; Caplin, BD; Boruc, O; Bruce-Cobbold, C; Cutillas, P; Dormann, D; Faull, P; Grossman, RC; Khadayate, S; Mas, VR; Nitsch, D; Wang, Z; Norman, J; Wilcox, CS; Wheeler, DC; Leiper, J; - view fewer (2015) Reduced renal methylarginine metabolism protects against progressive kidney damage. Journal of the American Society of Nephrology , 26 (12) pp. 3045-3059. 10.1681/ASN.2014030280.\n\nMoe, SM; Abdalla, S; Chertow, GM; Parfrey, P; Block, GA; Correa-Rotter, R; Floege, J; ... Drüeke, TB; + view all Moe, SM; Abdalla, S; Chertow, GM; Parfrey, P; Block, GA; Correa-Rotter, R; Floege, J; Herzog, CA; London, GM; Mahaffey, KW; Wheeler, DC; Dehmel, B; Goodman, WG; Drüeke, TB; - view fewer (2014) Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial. Journal of the American Society of Nephrology , 26 (6) pp. 1466-1475. 10.1681/ASN.2014040414."
    }
}